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Abstract
In order to ensure the accurate formation of two daughter cells from one parental
cell, the series of events that comprise the mitotic cell division cycle must be carefully
regulated. Much of this regulation affects the transitions between the stages of the cell
cycle, which are controlled by proteins known as cyclin dependent kinases (CDKs).
High levels of CDKs promote mitotic entry, whereas the inactivation of CDKs drives exit
from mitosis and entry into the next cell cycle at the G stage. In the budding yeast
Saccharomyces cerevisiae, the evolutionarily conserved phosphatase Cdcl4 regulates
many events in anaphase, including the inactivation of CDKs. The activity of Cdcl4 is
thought to be restricted to anaphase due to two signaling networks, the Cdc fourteen early
anaphase release (FEAR) network and the mitotic exit network (MEN). Although the
major components of these two pathways have been identified, their regulation is not
fully understood. Here we examine how the members of the FEAR network function
together to regulate Cdc 14 and its targets in anaphase. One function of Cdc 14 in early
anaphase is to promote proper segregation of ribosomal DNA (rDNA). We have
determined that Cdc14 is required to resolve a novel type of linkage between
chromosomes, which occurs at the rDNA locus due to transcription-dependent processes.
We also characterize the regulation of Cdc 14 activity by the FEAR network component
Spo 12. Specifically, we found that Spo 2 must be phosphorylated in a conserved domain
during anaphase in order for Cdc 14 to function in early anaphase. Spol2
phosphorylation is dependent on the CDK, Cdc28, whereas Cdcl4 contributes to the
dephosphorylation of Spol2. Lastly, we show that Spol2 phosphorylation is regulated
by the FEAR network components Espl and Slk19, but not by the MEN. Overall, this
thesis describes research that establishes a new model for both the regulation and
significance of the FEAR network in controlling Cdc 14 during anaphase in
Saccharomyces cerevisiae.
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Chapter I
Introduction
The careful orchestration of events in the cell division cycle is essential to
maintain genomic stability for long-term survival. In the budding yeast Saccharomyces
cerevisiae, the evolutionarily conserved phosphatase Cdcl4 is activated only after
chromosomes have been properly attached to the mitotic spindle. The spatiotemporal
control of Cdc 14 ensures timely CDK inactivation and mitotic exit. Two signaling
networks, the Cdc fourteen early anaphase release (FEAR) network and the mitotic exit
network (MEN) help restrict Cdcl4 activity to anaphase. Although the major
components of these two pathways have been identified, the regulation and
physiologically relevant targets of Cdc 14 release in anaphase are not yet fully
characterized. This thesis describes research that addresses some of the lingering
questions about Cdcl4 and enhances our understanding about early anaphase events in
Saccharomyces cerevisiae.
The activity of cyclin dependent kinases control the eukaryotic cell cycle
All eukaryotic organisms, whether multicellular or unicellular, must undergo cell
division in order to grow. During mitotic cell division, a series of events known as the
cell cycle culminates in the formation of two daughter cells from one parental cell.
Important stages during the cell cycle include gap 1 (G1), synthesis (S) phase, gap 2 (G2)
and finally the mitotic (M) phase, also known as mitosis. In late G , cells pass through a
point known START and are then committed to progress through the cell cycle. During
S phase, cells undergo DNA replication, during which the genome is duplicated, such that
each daughter can receive a complete genome upon completion of the cell cycle. The
mitotic phase can be divided into different temporal periods: prophase, metaphase,
anaphase, and telophase. During mitosis, newly condensed chromosomes are attached to
the mitotic spindle so that proper segregation can occur, after which the spindle is
disassembled and chromosomes decondense at the end of mitosis. Finally, the process of
cytokinesis physically divides the cytoplasm, resulting in the formation of two daughter
cells. These daughter cells are now in G and can pass through START to enter a new
cell cycle.
Controlling the transitions between the cell cycle stages is important to coordinate
all the necessary events that comprise the cell cycle. Premature cytokinesis or
chromosome missegregation occurring before all chromosomes are properly aligned on
the metaphase spindle can result in daughter cells receiving an abnormal chromosomal
complement, a state known as aneuploidy. Not surprisingly, the proper balance of
chromosomes in a cell is important for an organism's survival, as aneuploidy is
associated with many types of cancers and other diseases (37).
Cyclin dependent kinases (CDKs) trigger most cell cycle transitions. CDKs
phosphorylate proteins that regulate the cell cycle, which leads to many downstream
events that drive the cell cycle forward (21). In Saccharomyces cerevisiae, a single
CDK, Cdc28, is responsible for controlling cell cycle progression (20). A protein binding
partner known as a cyclin is required for CDK activity. Nine different cyclins control the
specificity and levels of Cdc28 activity during the different cell cycle stages (Figure 1)
(20). Clnl, Cln2, and Cln3 are the GI cyclins that function with Cdc28 to promote entry
into the cell cycle. The cyclins Clb5 and Clb6 start to accumulate at the end of G 1, and
S-phase CDKs
Figure 1: The activity of CDKs regulate the mitotic cell cycle
In Saccharomyces cerevisiae, the cyclin dependent kinase Cdc28 associates with different
regulatory cyclins to control the cell cycle. In late Gi, the cyclins Clnl, Cln2, and Cln3
promote entry past START and commitment to the mitotic cell division cycle. S-phase CDKs,
Clb5 and Clb6, function to promote DNA replication. At the onset of mitosis, the mitotic
CDKs Clbl, Clb2, Clb3 and Clb4 are activated and promote important mitotic events such as
chromosome condensation and formation of the spindle. Cells cannot exit the cell cycle until
mitotic CDKs have been inactivated, which in budding yeast is controlled by the phosphatase
Cdcl4. Upon CDK inactivation, cells undergo cytokinesis and the resulting daughter cells will
be in the Gi phase of the next cell cycle.
G1 CDKs Mitotic CDKs
are required during S-phase when their activity peaks. Lastly, the mitotic cyclins Clb 1,
Clb2, Clb3, and Clb4 are active during late S-phase and mitosis to promote chromosome
condensation and formation of the mitotic spindle. The extent of CDK activity during the
cell cycle is controlled mainly by the levels of available cyclin binding partners for
Cdc28. Therefore, the levels of cyclin proteins are tightly controlled in order to provide
proper regulation of cell cycle transitions.
In order to exit mitosis, cells establish a state of little to no CDK activity that
persists until late G of the next cell cycle (Figure 1). This requires inhibition of CDKs
and degradation of mitotic cyclins (21, 50). The metaphase to anaphase transition of
mitosis signals the initiation of mitotic cyclin degradation. Mitotic cyclins are targeted
for proteasomal degradation by the anaphase promoting complex/cyclosome (APC/C), a
ubiquitin-protein ligase (21). Specificity factors, Cdhl/Hctl or Cdc20, bind to the
APC/C to control which proteins are ubiquitinated (21). Cdhl targets Clbs for
ubiquitination by the APC/C, leading to their degradation by the proteasome (27). Since
mitotic cyclins persist until anaphase in budding yeast, additional mechanisms beyond
degradation are required to inactivate mitotic CDK activity. Therefore during anaphase,
a mitotic CDK inhibitor Sic 1 becomes stabilized (44). Interestingly, Cdc28 kinase
activity antagonizes these events, as Cdc28 phosphorylates Sic to target it for
destruction and phosphorylates Cdhl to inactivate it (28). How do cells resolve this
power struggle between mitotic CDKs and the mechanisms for their inactivation? The
characterization of the essential phosphatase Cdcl4 and its regulation in budding yeast,
explains how mitotic CDK activity is ultimately lost during anaphase allowing mitotic
exit to occur.
Cdcl4 promotes mitotic CDK inactivation
In budding yeast, Cdcl4 is an essential phosphatase, and homologs exist in most
fungi and animal species (33). Cdcl4 is a serine/threonine protein phosphatase that
antagonizes mitotic CDK activity in multiple ways (44). In late anaphase, Cdcl4
dephosphorylates Sic 1, the mitotic CDK inhibitor, which prevents its degradation (44).
Besides stabilizing Sic l, Cdc 14 also activates transcription of SIC]. This is achieved by
the dephosphorylation of the transcription factor Swi5, thereby allowing Swi5 to enter the
nucleus and upregulate the transcription of SIC] (44). Lastly, Cdcl4 dephosphorylates
the APC/C specificity factor Cdhl/Hctl (15). Once dephosphorylated, Cdhl is active
and able to contribute to mitotic cyclin degradation (27). Interestingly, cdhlA cells fail to
degrade Clb2, the main mitotic cyclin, but are viable (46). This is likely due to the
accumulation of Sic 1, which inhibits Clb2 activity. Cells that lack SIC] are also viable
because Clb2 can be degraded to allow exit from mitosis (46, 50). However, cells
lacking both CDH1 and SIC] are synthetically lethal, implying that at least one of these
mechanisms to reduce mitotic CDK activity must be in place in order to exit from mitosis
(46). Examining the phenotype of cells in which CDC14 has been mutated further
supports this idea. These cells arrest in anaphase, as they are unable to exit from mitosis
because they fail to accumulate Sic 1 and the levels of mitotic cyclins, such as Clb2, stay
high (44). The dephosphorylation of Sic l, Swi5, and Cdhl by Cdcl4 allows for mitotic
CDKs to be inactivated at the end of mitosis in Saccharomyces cerevisiae, thereby
driving cells into G1 (44). However, as Cdc 14 has other targets during mitosis and some
targets likely still remain unknown, the magnitude of Cdcl4's significance during mitosis
is likely to be even greater.
Cdcl4 is released from nucleolar sequestration in anaphase
Since Cdc 14 protein levels are constant through the cell cycle, how is the activity
of Cdcl4 restricted to anaphase? The discovery of the protein Cdcl4 inhibitor 1 (Cfil),
also known as Netl, indicated that by tightly controlling the localization of Cdc 14 in the
cell, the dephosphorylation of mitotic exit substrates could be restricted to anaphase (45).
Cfil/Net resides in the nucleolus throughout the cell cycle and is associated with the
ribosomal DNA (rDNA) array (11). The nucleolus is a nuclear structure that is
assembled via protein-protein interactions around the two hundred copies of the rDNA
repeat in budding yeast in order to transcribe the rDNA and assemble ribosomes (31). In
budding yeast, even a single rDNA repeat carried on a plasmid results in mini-nucleoli
forming around that single repeat (23). Overall, work examining differently structured
rDNA arrays has shown that both the physical organization of the rDNA genes and the
type of polymerase that transcribes them influence the cytology of the nucleolus (23).
Cfi 1/Netl is part of the regulator of nucleolar silencing and telophase exit
(RENT) complex, which functions to prevent transcription of a subset of the rDNA
repeats and prevents recombination at the rDNA array (11). Sir2, Cfil/Netl, Fobl, and
Cdcl4 are the known components of this complex (11). Recently, the Tof2 protein has
been shown to interact with the RENT complex and enhances Cdcl4 phosphatase activity
in vitro (9). Unlike Fob and Sir2, Cfil is important for both transcription at the rDNA
and integrity of the nucleolus, because cfilA cells have reduced rDNA transcription and
partially delocalized nucleolar proteins (32).
Another characteristic of cfilA cells is that Cdcl4 becomes mislocalized (45). In
wild-type cells, Cdc 14 is sequestered in the nucleolus throughout most of the cell cycle
(Figure 2) (45). During anaphase, Cdcl4 becomes released from the nucleolus allowing
it to interact with and dephosphorylate substrates that drive mitotic exit (Figure 2) (45).
Beyond co-localizing with Cdcl4 and keeping it sequestered in the nucleolus throughout
most of the cell cycle, Cfil also inhibits Cdcl4 phosphatase activity. Cdcl4 has higher
phosphatase activity in vitro when purified from cells lacking CFI1 (40). Addition of
purified Cfil to the in vitro phosphatase reaction impairs the dephosphorylation of Cdcl4
substrates (40). Cfil can interact with both full-length protein Cdcl4 and a Cdcl4
truncation lacking the non-essential C-terminus, indicating that Cfil likely binds near the
active site of the Cdcl4 (40). Given these results, Cfi 1 is considered a competitive
inhibitor of Cdc 14. Cfil also undergoes Clb2-CDK and Cdc5 kinase-dependent
phosphorylation (1,47). The current model is that as Cfi 1 becomes phosphorylated,
phosphorylation destabilizes the Cfil and Cdcl4 interaction. This results in Cfil
releasing Cdcl4, which can leave the nucleolus.
B 0
C
c
Figure 2: Cdcl4 is sequestered in the nucleolus throughout the cell cycle
until anaphase
Using indirect immunofluorescence, the localization of Cdc 14 (red) was followed throughout
the stages of the cell cycle (left panels). Tubulin staining (green) was used to ascertain cell
cycle stage (middle panels). Merged images with DNA (blue) are shown in the right panels.
(A) In G1 cells, Cdcl4 is sequestered in the nucleolus.
(B) In metaphase cells, Cdc 14 remains sequestered in the nucleolus.
(C) In anaphase cells, Cdcl 14 is released from the nucleolus in two waves, early and late
anaphase. Upon release, Cdc 14 can be found in the nucleolus and cytoplasm where it
dephosphorylates its mitotic exit substrates.
(Slide modified from Visintin et. al 2008)
Two signaling pathways control Cdcl4 release from the nucleolus
Two pathways control the release of Cdc14 from the nucleolus during anaphase
(Figure 3) (33). In early anaphase, the Cdcl4 early anaphase release (FEAR) network
contributes to the transient release of Cdc 14 from the nucleolus and into the nucleus (35).
This release of Cdc 14 is not essential for mitotic exit, as FEAR network mutants are
viable, but they do display a delay in exit from mitosis (35). The FEAR network includes
the polo-like kinase Cdc5, the separase Espl, the kinetochore protein Slkl9, the nuclear
protein Spo 12, and the replication fork block protein Fob1 (35). Recently the
phosphatase Cdc55 was shown to be an inhibitor of the FEAR network (26). A second
wave of Cdc 14 is released in late anaphase by the mitotic exit network (MEN) (2, 8).
The essential MEN signaling pathway most closely resembles a Ras-like GTPase
signaling cascade. Components of the MEN include the scaffold protein Nudl, the
GTPase Teml, the two component GTPase activating protein (GAP) Bub2-Bfal, the
putative guanine nucleotide exchange factor (GEF) Ltel, the protein kinases Cdc 15,
Dbf2, and Cdc5, and the Dbf2 activating protein Mob1 (2, 8). The essential release by
the MEN of Cdc 14 from the nucleolus allows Cdc 14 to enter the nucleus and cytoplasm,
where it interacts with its important CDK inactivation substrates to trigger mitotic exit.
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Figure 3: Signaling pathways regulating the release of Cdcl4 from the
nucleolus
Two pathways control the release of Cdcl4 from its inhibitor Cfil in the nucleolus during
anaphase. In early anaphase, the Cdc 14 early anaphase release (FEAR) network contributes to
the transient release of Cdcl4 out of the nucleolus and into the nucleus. FEAR network
components include the polo-like kinase Cdc5, the separase Espl, the kinetochore protein
Slk19, the nuclear protein Spol2, as well as two inhibitors of release, the replication fork block
protein Fobl and phosphatase Cdc55. After release by the FEAR network, Cdcl4 requires the
activity of the mitotic exit network (MEN) to maintain release Cdcl4 in late anaphase to both
the nucleus and cytoplasm. The MEN resembles a Ras-like GTPase signaling cascade and
includes the scaffold protein Nudl, the GTPase Teml, the two component GTPase activating
protein (GAP) Bub2-Bfal, the putative guanine nucleotide exchange factor (GEF) Ltel, and
the protein kinases Cdc5, Cdcl5, and Dbf2 and its activator Mobl.
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Cdcl4 released by the MEN is responsible for initiating the sequence of events
that lead to exit from mitosis, and the MEN may also play a role in cytokinesis (33). The
activity of the MEN seems to be restricted to anaphase due to the changes in localization
of the MEN components during the cell cycle. The spindle pole body (SPB) in budding
yeast has been referred to as a "signaling beacon" for the MEN because recruitment of
the MEN components to the SPB is necessary for full activation of the MEN (43). Teml
accumulates during mitosis and localizes to the SPB that migrates into the bud (43). Ltel
is localized throughout the cell in G1, but upon formation of a bud, Ltel becomes
asymmetrically localized to the bud cortex, and later can also be seen in the bud
cytoplasm (29). Upon exit from mitosis, Ltel asymmetry is lost and is again seen
uniformly throughout the cell (29). During anaphase, Dbf2 and Cdc 15 are localized to
both SPBs (43). The SPB protein Nudl functions as a scaffold for this pathway, and is
required for recruitment of Teml, Cdc 15, and Dbf2 to the SPB (43).
Examining the localization of the MEN components to the SPB and analysis of
Dbf2 activity in different MEN mutants, has allowed the pathway to be ordered
genetically (43). Teml localization to SPBs is independent of Cdc 14, Cdc5, Cdcl5 and
Dbf2 (43). The SPB localization of Cdcl5 is dependent on Teml but not on Cdcl4 or
Dbf2 (43). The recruitment of Dbf2 to the SPB requires Teml and Cdcl5 but not Cdcl4
(43). Additionally, cells lacking BUB2 load Cdc 15 and Dbf2 onto SPB prematurely (43).
All of these observations argue that Bub2 is a negative regulator of the MEN, and Teml
is the most upstream activating component. Cdc 15 is downstream of Teml, and Dbf2 is
downstream of Cdc 15 since Dbf2 recruitment to SPBs and kinase activity requires both
Teml and Cdcl5 (43). The ultimate effector of the MEN pathway is Cdcl4, as none of
the MEN components require Cdcl4 for their SPB localization (43). Cdc5 is harder to
place within the MEN pathway as it contributes to the release of Cdcl4 from the
nucleolus as a FEAR network component as well (Figure 3).
An important question is how the MEN is ultimately shut off and how Cdc 14
becomes resequestered in the nucleolus after mitotic exit. To explain the resequestration
of Cdc 14 after MEN inactivation, a simple hypothesis would be that the actively released
Cdc 14 is somehow degraded, and the resequestered Cdcl4 found back in the nucleolus
after mitotic exit is a newly synthesized protein population. However, it has been shown
this is not the case, as protein synthesis was not needed for resequestration of Cdc 14 (42).
Instead the APC/C specificity factor Cdhl was shown to be important for timely
resequestration of Cdcl4 (42). Examination of its anaphase substrates Cdc5, Spol2, and
Clb-CDKs revealed that the Cdhl-targeted degradation of Cdc5 is important for the
reaccumulation of Cdc 14 in the nucleolus (42). In fact, Cdcl4 can be effectively
resequestered in the nucleolus in cdhlA cells, if Cdc5 is artificially degraded (42).
Therefore, the current model is that the MEN releases active Cdc 14, which
dephosphorylates Cdhl, leading to APC/CCdhl mediated degradation of Cdc5, which halts
MEN activation. So by contributing to the degradation of Cdc5 in late anaphase, Cdc 14
actually helps initiate the curtailing of its own release. Additionally, Cdc 14
dephosphorylates both Bfal and Ltel, which triggers release of Ltel from the bud cortex
and likely restores the GAP activity of Bub2-Bfal towards Teml, all contributing to the
dampening of the MEN release of Cdcl4 (2, 29, 33).
Cdcl4 Early Anaphase Release Pathway
Although the FEAR network release of Cdc 14 is not essential in a normal cell
cycle, FEAR network mutants display a reproducible delay in mitotic exit (35). The
FEAR network was discovered by examining Cdcl4 release in MEN mutants such as
cdcl5-2 cells (35). These MEN mutants showed a transient release of Cdc 14 in early
anaphase, indicating the existence of another pathway separate from the MEN that
contributes to the release of Cdc 14 from the nucleolus. The polo-like kinase Cdc5 is a
component of both the MEN and the FEAR network, as cdc5-1 cells at the restrictive
temperature did not show significant Cdc 14 release (35).
The protease separase, Esp in budding yeast, was also shown to be a FEAR
network component (35). Espl plays an important role in regulating the metaphase to
anaphase transition, when sister-chromatid separation begins. Separase is normally kept
inactive by its inhibitor securin, Pdsl in budding yeast (22). However, at the onset of
anaphase, APC/CCdc 20 ubiquitinates Pds 1, thereby targeting it for proteasomal
degradation (22). No longer inactive, separase now cleaves the Sccl subunit of the
cohesin complex that holds sister chromatids together, allowing sister chromatids to
separate.
Although, the proteolytic activity of Esp 1 is not required for its FEAR network
function, Cdc 14 release was examined in mutants of the two defined substrates for Esp 1,
the cohesin subunit Sccl and the kinetochore protein Slkl9 (35, 36). Slkl9 was
determined to be required for the FEAR network release of Cdc 14, because slkl9A cells
have defects releasing Cdcl4 (33). Slkl9 localizes to the kinetochore in metaphase and
translocates to the spindle midzone during anaphase (36). The majority of Slkl9 protein
is cleaved at anaphase onset, and its C-terminal cleavage product is stable throughout
anaphase (36). Interestingly, the uncleavable form of Slkl9 shows normal localization
throughout the cell cycle (36). Additionally, the cleavage of Slkl9 does not seem to be
required for FEAR network function, as expression of a non-cleavable version of Slkl 9
does rescue the Cdcl4 release defects in slkl9A cells (35). Therefore, the function of
Slkl9 cleavage during anaphase is currently unclear.
Spol2 was shown to be a component of the FEAR network, as spol2A cells have
a decrease in the early anaphase release of Cdc 14 (35). Additionally, over-expression of
SPO12 had been shown to rescue the temperature sensitive lethality of MEN mutants
(34). Spol2 localizes to the nucleus and nucleolus throughout the cell cycle, and its
protein levels peak in anaphase, after which APC/CCdhl targets it for degradation (30).
The mitotic exit function of Spo 12 depends on an intact C-terminal region (34). Within
this region exits a conserved domain called double serine proline box (DSP-box), named
after the conserved amino acids serine 118, proline 119, serine 125, and proline 126 (34).
These amino acids are essential for the mitotic exit function of Spo 12 (34). Mutating
these amino acids did not change the stability or levels of the Spol2 protein, but led to
loss of function (34). Furthermore, these two serines were shown to be the main two sites
of phosphorylation on the Spol2 protein (34). Work described in this thesis addresses
the timing, significance, and regulation of Spo 12 phosphorylation.
A protein found by yeast two-hybrid to interact with Spol2, Fob 1, is an inhibitor
of the FEAR network (34). Fob 1 is a nucleolar protein that has been previously
characterized in regulating replication and recombination within the rDNA (12, 16).
Fob protein levels are constant throughout the cell cycle and the protein remains
consistently localized in the nucleolus (34). Overproduction of Spol2 no longer rescues
the temperature sensitive lethality of cdc15-2 mutants in the presence of overexpressed
FOB], so Fobl is likely to be functioning downstream of or in parallel to Spol2 (34). In
fact, Fobl and Spol2 physically interact, and this interaction is slightly weakened as cells
entered anaphase (34). Additionally, a phospho-mutant version of Spol2 interacted more
strongly with Fob1 (34). These observations lead to the current model that Fob and
Spol2 interact throughout most of the cell cycle. However, as cells enter anaphase,
Spo 12 is phosphorylated, which decreases its affinity for Fob 1, alleviating the inhibitory
effects of Fob 1 on the FEAR network release of Cdc 14.
To order the FEAR network components Cdc5, Espl, Slkl9 and Spol2 in a
pathway, experiments were conducted to test the ability of overexpression of one FEAR
network component to rescue the Cdc 14 release defects in another FEAR network mutant
(47). In slkl9A cells, overexpression of either CDC5 or SP012 can rescue Cdcl4 release
defects whereas overexpression of ESP1 cannot (47). This indicates that Esp 1 functions
upstream of Slkl9 to induce Cdc14 release. This data also suggests that Cdc5 and Spol2
function either downstream or in parallel to Espl. In spol2A cells, overexpression of
CDC5 can rescue Cdc 14 release defects whereas overexpression of ESP1 cannot, so
Cdc5 has a role downstream of or in parallel to Spol2 (47). Interestingly, whereas
overexpression of either CDC5 or SP012 can rescue the Cdc14 release defects of cdcl5-
2 mutants, only GAL-CDC5 can ectopically release Cdcl4 prematurely in metaphase,
whereas GAL-SP012 cannot (47). This suggests that there is something about Spol2 that
makes it a potent activator of Cdcl4 release only in anaphase. One hypothesis is that this
may be due to Spol2 phosphorylation. Cells lacking SP012 seem to enhance the mitotic
exit defect of espl-1 and slkl9A cells mutant cells indicating that Spol2 is likely to be
functioning in a parallel branch of the FEAR pathway (47). Ongoing experiments are
being conducted to examine this hypothesis. Lastly, overexpression of CDC5 in S-phase
cells, can release Cdcl4 in a manner that is not dependent on an active MEN or on Esp
mediated FEAR network activity (47). This is another piece of evidence that suggests
that Cdc5 functions in a separate branch of the FEAR pathway to induce Cdc 14 release
(Figure 3).
Recently, one of the regulatory subunits of the yeast phosphatase PP2A, Cdc55,
was implicated in mitotic exit. Cells lacking CDC55 show a premature and partial
release of Cdc 14 from the nucleolus (26, 49). Additionally, the deletion of CDC55
rescues the lethality caused by the FEAR network and the MEN double mutant spol2A
ItelA (54). This indicates that Cdc55 normally negatively regulates Cdc14 release and
mitotic exit. Recently published work also suggests that Cdc55 normally functions to
keep Cfil/Netl under-phosphorylated by Cdc28 (26). The proposed model is that upon
separase activation at the metaphase to anaphase transition, separase downregulates
PP2A/Cdc55, which allows Cfil to exist in a more hyper-phosphorylated state that
contributes to its release of Cdcl4 from the nucleolus in early anaphase (Figure 3) (1,
26). However, my data calls some of this into question. Instead, it looks like the position
of Cdc55 may be upstream of Espl. Therefore, additional work needs to be done to
clearly determine how Cdc55 affects all the components of the FEAR pathway.
Functions of Cdcl4 released by the FEAR network in mitosis
Even though it is not essential in a normal cell cycle, the FEAR network helps to
activate the MEN. This is accomplished by early anaphase released Cdcl4
dephosphorylating Cdc 15, which enhances Cdcl5 kinase activity (33). Additionally,
Cdc 14 released by the FEAR network has different substrates than the Cdcl4 released by
the MEN (Figure 4) (33). Cdcl4 released by the FEAR network promotes spindle
stabilization. Cdcl4 dephosphorylates Sli15 and causes the translocation of the
chromosomal passenger proteins Ipll and Sli 15 from the kinetochores to the spindle
midzone, which appears to stabilize spindles (25). Cdcl4 released in early anaphase also
dephosphorylates microtubule-stabilizing proteins Fin1 and Ask1 (10, 53). Additionally,
Cdc 14 targets other microtubule-stabilizing proteins, such as Ndc 10 and Stu 1, to the
spindle in anaphase through the dephosphorylation of the microtubule-associated protein
Ase 1 (10). Overall, Cdcl4 helps stabilize the spindle at the onset of anaphase, after
chromosomes have been properly attached.
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Figure 4: Currently known substrates and functions of Cdcl4 in mitosis
Cdcl4 released by FEAR helps activate the MEN and contributes to the translocation of
chromosomal passenger proteins to stabilize the spindle. Additionally, FEAR network
released Cdc 14 is required for proper segregation of telomeres and rDNA, the exact
mechanism of how this is achieved is still being studied. Cdc 14 released by MEN contributes
to the inactivation of mitotic CDKs through the dephosphorylation of its substrates Cdhl, Sic 1,
Swi5. These models about Cdcl4 continue to be refined, so to reflect this, dashed arrows
indicate more recently discovered potential targets and solid arrows indicate well-characterized
Cdc 14 targets.
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Cdc 14 released by the FEAR network also plays a role in the proper segregation
of specialized genomic regions such as the rDNA and telomeres (7, 38, 48).
Overexpression of CDC14 is sufficient to induce premature rDNA separation during
metaphase (7). The mechanism whereby Cdcl4 promotes rDNA segregation is thought
to involve the recruitment of the condensin complex to repetitive genomic regions.
Condensin is a protein complex that mediates chromosome compaction, yet its function
at the rDNA in yeast seems to be partly independent of its role in condensation (7).
Understanding the unique dependence of the repetitive rDNA array on Cdcl4 for
segregation is a topic that will be explored in this thesis.
The functions of the FEAR network in meiosis
Unlike mitosis, in meiosis cells undergo two rounds of chromosome segregation,
meiosis I and meiosis II respectively, following a single round of DNA replication.
During meiosis I homologous chromosomes segregate, and in meiosis II sister chromatids
segregate, resulting in the production of four haploid spores from a single diploid cell.
FEAR network components have also been shown to be important in meiosis (4, 19).
Neither slkJ9A nor spol2A diploid cells form tri/tetranucleate cells like wild type diploids
(4, 19). Problems in meiosis occur in these mutants, because cells need Slkl9, Spol2,
and Espl to release Cdcl4 from the nucleolus in meiosis I (4, 19). Additionally, a delay
in the disassembly of the anaphase I spindle has been observed in SLK19, SP012, and
CDC14 mutants, indicating these cells may have problems dampening CDK activity,
which is required for spindle disassembly (19). Interestingly, Slkl9 and Spol2 are also
required for proper segregation of the maternal and paternal rDNA during anaphase I,
likely due to their requirement for Cdc 14 release (4). As in mitosis, the components of
the FEAR network contribute to release Cdc 14, which is needed to coordinate meiotic
events.
Cdcl4 in other eukaryotes
Homologs of the phosphatase Cdc 14 are found in most if not all other eukaryotes.
Based on the importance of Cdcl4 in regulating mitotic exit in budding yeast, work is
being actively conducted to determine whether Cdcl4 homologs play a similar role in
other organisms.
The Cdc 14 homolog in fission yeast Schizosaccharomyces pombe is the
Clpl/Flpl phosphatase (6, 39). Although this gene is not essential, deletion of CLPI
results in premature mitotic entry and problems during cytokinesis. Like Cdc 14, Clpl
contributes to the inactivation of mitotic-CDKs, but this happens primarily in G2 before
mitosis (39). For this reason, cells overexpressing CLPI arrest in G2 because they cannot
activate mitotic CDKs (6, 39). Clpl dephosphorylates Cdc25 and targets it for
ubiquitination by the APC/C, which results in the degradation of Cdc25 by the
proteasome (6, 39, 51). Cdc25 normally functions to dephosphorylate tyrosine 15 on the
CDK Cdc2/Cdkl, which activates it. So by targeting Cdc25 for degradation, Clpl keeps
Cdkl inactive. Clpl further contributes to tyrosine 15 phosphorylation on Cdkl by
activating the Weel kinase that is responsible for this modification (6, 39). During
mitosis, Cdkl has been implicated in phosphorylating Clpl in a manner than inactivates
it, resulting in a positive feedback loop for mitotic CDK activity (52).
Clp is localized in the nucleolus and at the spindle pole body until mitosis, when
it is released from the nucleolus to associate with mitotic spindles (6, 39). A GTPase
signaling cascade homologous to the MEN pathway called the septation initiation
network (SIN) is needed to maintain Clp 1 in its released state when the cytokinesis
checkpoint has been activated (2). FEAR network homologs in fission yeast do not
promote release of Clpl and Clpl is not required for rDNA segregation (5). Therefore,
even though not all of the functions of Cdc 14 are conserved among yeasts, both
Clpl/Flpl and Cdc 14 contribute to the inactivation of mitotic CDKs and
dephosphorylation of CDK substrates.
Xenopus has two Cdcl4 homologs, XCdcl4alpha and XCdcl4beta, which are
localized to the nucleolus and centrosome (13). XCdcl4alpha is a phospho-protein and is
required for normal cell division in embryos (13). There are also two Cdcl4 homologs in
humans, hCdcl4A and hCdc 14B. Interestingly, defects in cells deficient for the Cdcl4
homolog Clpl/Flpl are rescued by the expression hCdcl4A/B expression in fission yeast
(41). The hCdcl4B protein resides in the nucleolus until the start of mitosis when it
becomes localized to the chromosomes (14). Although human cells lacking hCdcl4B are
viable with no apparent problems segregating rDNA or exiting mitosis, there does seem
to be an effect on spindle stability (3). hCdcl4A localizes to centrosomes and affects the
process of centrosome duplication (14). Polo like kinase 1 (Plkl), a homolog of budding
yeast Cdc5, interacts with and phosphorylates hCdcl4A, which releases the auto-
inhibition of hCdcl4A (55). Human tissues and cancer cell lines have been shown to
have varying levels of hCdc 14A expression (24). As hCdcl4A can interact with the
tumor suppressor protein p53 and de-phosphorylate it, it will be interesting to explore if
hCdc 14A has any role in tumor progression (17, 24). It also remains to be seen if there
are any signaling pathways in higher eukaryotes homologous to those in yeast that
regulate Cdcl4 functions.
Conclusions and Perspectives
Much progress has been made in understanding cell cycle regulation, specifically
the exit from mitosis. In budding yeast, an integral component of these mitotic events is
the phosphatase Cdc 14. The canonical role ascribed to Cdcl4 is the dephosphorylation
of mitotic CDK substrates leading to CDK inactivation. Once cells are in a state of low
Clb-CDK activity, cells will exit from mitosis and can restart the cell cycle in the
following GI state.
Two signaling networks have been defined that regulate the release of Cdc14
from its sequestration in the nucleolus, the FEAR network and the MEN. Cdcl4 released
by the FEAR network regulates anaphase, contributing to the timely segregation of
rDNA. Understanding how Cdcl4 accomplishes this and why these genomic regions
need additional assistance to segregate properly are areas of continued study. Chapter 2
will describe data indicating that the high levels of transcription at the rDNA are the basis
for the requirement of Cdc 14 for segregation, and that eliminating transcription alleviates
the need for Cdc 14 for segregation. The details of how the different components of the
FEAR pathway cause the release of Cdc 14 in early anaphase is another topic still being
explored. Chapter 3 will describe that the phosphorylation of the FEAR network
component Spo 12 is essential for the mitotic exit function of Spo 12, and how
understanding the regulation of this phosphorylation event is shedding light on the order
and timing of the function of other FEAR network components. Lastly, Appendix I will
discuss a novel temperature-sensitive allele of Cdc 14 that upon further study may provide
more insight into the regulation of Cdc 14 localization. Improving our understanding of
how Cdc 14 is regulated and functions in budding yeast may in turn help enhance our
currently more limited knowledge on how Cdcl4 homologs function in higher
eukaryotes.
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Summary
The rDNA is a specialized genomic region not only owing to its function as the
nucleolar organizing region (NOR), but also because it is repetitive in nature and, at least in
budding yeast, silenced for Pol II mediated transcription. Furthermore, cohesin independent
linkages hold the sister-chromatids together at the rDNA loci and their resolution requires
the activity of the conserved protein phosphatase Cdc 14. Here we show that rRNA
transcription-dependent processes establish linkages at the rDNA, which affect segregation
of this locus. Inactivation of Cfil/Netl, a protein required for efficient rRNA transcription,
or elimination of Pol I activity, which drives rRNA transcription, diminishes the need for
CDC14 in rDNA segregation. Our results identify Pol I transcription-dependent processes
as a novel means of establishing linkages between chromosomes.
Introduction
Chromosome segregation is mediated by the removal of cohesin complexes, which
hold sister chromatids together (24). A protease known as Separase removes cohesins from
chromosomes by cleaving one of the cohesin subunits. Recently, it has become clear that
segregation of the genes encoding rRNAs (rDNA), which are clustered in long tandem
repeats on chromosome XII, require mechanisms in addition to cohesin removal for their
segregation in budding yeast (6, 37, 40, 44). This observation is perhaps not surprising
given that this genomic region is unique in several ways. First, owing to its repetitive
nature, the rDNA is thought to be unstable (19). Second, the rDNA has the ability to
organize an organelle, the nucleolus, around it (reviewed in 31). Third, 60 percent of all
cellular transcription occurs at the rDNA, which is mediated by RNA Polymerase I and
Polymerase III (reviewed in 45). Fourth, DNA replication is largely unidirectional,
coinciding with the direction of rRNA transcription (16). Fifth, the rDNA is silenced for
Pol II mediated transcription (5). Finally, at least in yeast, the rDNA segregates late during
mitosis and meiosis (6, 13, 14).
The necessary mechanisms for rDNA segregation, in addition to cohesin removal,
have been defined at some level. The protein phosphatase Cdc 14, which is best known for
its role in bringing about exit from mitosis, promotes rDNA segregation at least in part by
targeting condensin, a protein complex required for chromosome condensation, to the
rDNA (6, 37, 44). Cdcl4 itself is regulated by an inhibitor Cfil/Netl that holds the protein
inactive in the nucleolus during most of the cell cycle (reviewed in 35). During anaphase,
two regulatory networks, the Cdcl4 Early Anaphase Release (FEAR) network and the
Mitotic Exit Network (MEN) promote the dissociation of Cdc 14 from its inhibitor. Cdc 14
activated by the FEAR network during early anaphase is primarily responsible for
promoting rDNA and nucleolar segregation (6, 37, 40, 44). Why the rDNA requires Cdcl4
for its segregation is not known, but it is clear that mechanisms in addition to cohesin-
mediated cohesion enhance the cohesiveness of this genomic region, which are revealed
when CDC14 is inactive. Throughout the text we will refer to this cohesiveness at the
rDNA that is observed in cdcl4 and FEAR network mutants as "cohesin-independent
linkages" or just as "linkages" at the rDNA.
Here we investigate the nature of the linkages at the rDNA that require CDC14 and
the FEAR network for their segregation. Our studies revealed that rDNA transcription
imposes a need for CDC14 on rDNA segregation. By deleting factors involved in efficient
rDNA transcription or eliminating RNA polymerase I (Pol I) transcription we show that
rDNA segregation no longer relies on Cdc 14 activity. The linkages at the rDNA caused by
transcription are not Pol I specific, as rDNA segregation also requires CDC14 function
when rRNA transcription is mediated by Pol II. We furthermore find that eliminating
transcription also partially suppresses the rDNA segregation defect of cells defective in
condensin function. Our results suggest that the production of rRNA and/or factors that
assemble onto the rRNA represent a novel way of establishing linkages between
chromosomes and impose a need for Cdcl4 and condensin on rDNA and nucleolar
segregation.
Results
An rDNA array of only 25 repeats segregates as poorly as a 150 repeat array in cdcl4-
3 mutants.
In wild-type W303 yeast strains, the rDNA locus is composed of about 150 repeats
(29). To determine whether the number of rDNA repeats influences the segregation
behavior of this chromosomal region we analyzed cdcl4-3 mutants carrying either the
wild-type rDNA array or 25 copies of the repeat (confirmed by Southern Blot analysis, data
not shown; note that cdcl4-3 mutants carried a deletion in FOB1 to stably propagate 25
rDNA repeats (11, 27)). Cells were synchronized in GI and then released into the cell cycle
at 370 C to inactivate the cdcl4-3 gene product. As cells progressed through the cell cycle
we examined when the nucleolus segregated by indirect immunofluorescence using an
antibody against the nucleolar protein Nopl. As reported previously, cdcl4-3 mutants
arrested in anaphase with largely unsegregated nucleoli (Figure lA, B; 6, 14, 37, 40, 44).
Reduction of the rDNA repeat number to 25 did not ameliorate the nucleolar segregation
defect of cdcl4-3 mutants (Figure lA, B). In fact, nucleolar segregation was less efficient
than that of a wild-type array (Figure lA). A wild-type strain with 25 rDNA repeats
segregated without any delays (data not shown). Thus, even a short rDNA locus requires
CDC14 for its segregation.
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Figure 1: rDNA repeat number does not affect rDNA segregation in
cdcl4-3 mutants.
(A) cdc14-3 (A5321), cdcl4-3foblA (A10676), and cdcl4-3foblA, 25xRDN1 (A14628)
cells were arrested in G with a-factor (5 pg/ml) followed by release into fresh medium
at 370C. The percentage of cells in anaphase was determined using tubulin staining at
indicated times after release (left panel). Nucleolar segregation in anaphase cells was
determined as described in Materials and Methods using Nop 1 and is shown in the right
panel. At least 50 anaphase cells were analyzed.
(B) Examples of unsegregated (top) and segregated (bottom) nucleolar masses in
anaphase cells. Nopl staining is shown in red, anti-tubulin staining in green and DNA in
blue.
(C) Schematic representation of the location of the rDNA GFP dot on chromosome XII.
(D) Wild-type cells (A14615; wt RDN1) cells carrying 400 copies of the rDNA (A14742;
rpa135A, rrn9A, 400xRDN1), cdcl4-3 mutants carrying a wild-type rDNA array (A14617;
cdcl4-3, wt RDN1), and cdcl4-3 mutants carrying 400 copies of the rDNA array (A14743;
cdcl4-3, rpa135A, rrn9A , 400xRDN1) are all carrying rDNA GFP dots and were grown at
370 C for 140 minutes and anaphase cells were scored for segregation of the rDNA-GFP
dots as described in Materials and Methods.
We also examined cdcl4-3 mutants bearing 400 copies of the rDNA repeat. Cells
lacking the RNA polymerase I subunit RPA135 and in addition carry a deletion of the
Upstream Activation Factor (UAF) component RRN9 inefficiently transcribe the rRNA
using RNA polymerase II (27). As a result these polymerase-switched cells carry an
increased number of rDNA repeats (approximately 400 copies; 27) to compensate for this
decrease in rRNA transcription. To compare the segregation of this expanded rDNA locus
accurately with that of a wild-type array we analyzed the segregation of an array of tet
operator (tetO) sequences integrated next to the rDNA locus proximal to the telomere
(Figure IC; henceforth rDNA GFP dots; 6). The segregation behavior of this array can be
examined by expressing a tet repressor - GFP fusion in cells (38). Because cells lacking
RPA135 and RRN9 grow very slowly (27) we analyzed rDNA segregation only in anaphase
cells rather than in cells progressing through the cell cycle in a synchronous manner. Wild-
type cells carrying 400 copies of the rDNA (confirmed by Southern blot analysis, data not
shown) segregated rDNA GFP dots between mother and daughter cells as efficiently as
cells carrying 150 copies of rDNA (Figure ID). Furthermore, an array of 400 rDNA repeats
(confirmed by Southern blot analysis, data not shown) did not further impair rDNA GFP-
dot segregation in cdcl4-3 mutants (Figure ID). These results do not exclude the
possibility that rDNA array size does not influence the segregation of the rDNA at all, but
our findings do suggest that repeat length within the range tested does not impose a need
for CDC14 on rDNA segregation.
Recombination does not cause rDNA segregation defects in cdc14-3 mutants.
The rDNA locus can undergo contraction and expansion (reviewed in 15), which
are mediated by recombination and, in yeast, involve the replication fork barrier protein
Fobl (7, 19-21, 23). Deletion of FOB1 does not improve rDNA segregation in cdcl4-3
mutants, but in fact slightly worsened the process (Figure 1A; 37). Inactivation of the
homologous recombination machinery (by deleting RAD52; 37), or of the non-homologous
end-joining pathway (by deleting DNL4), or the single strand annealing recombination
pathway (by deleting RADI) did not allow the nucleolus to segregate efficiently in cdcl4-3
mutants either (Figure 2, data not shown). Nor did double and triple mutant combinations
affect rDNA segregation in cdcl4-3 mutants (Figure 2). To control for the possibility that
inactivation of recombination factors themselves causes rDNA segregation defects we
examined the consequences of deleting either RAD52 or DNL4 or RAD1 in cdcl5-2
mutants, which like the cdc14-3 mutants arrest in anaphase but do not exhibit rDNA
segregation defects (6). Inactivation of these recombination factors did not affect rDNA
segregation in a cdc15-2 mutant (Figure 2, data not shown). Our results indicate that
neither homologous recombination, nor non-homologous end joining, nor single strand
annealing generates the linkages between sister chromatids at the rDNA that need resolving
by Cdc 14.
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Figure 2: Inactivation of recombination pathways does not rescue the
rDNA segregation defect of cdcl4-3 mutants.
(A) Cells were arrested in G 1 in YEPD with a-factor (5 [tg/ml) and released into the cell
cycle at 370C. Samples of cdcl5-2 (A2596), cdc15-2, rad52A (A12734), cdcl4-3
(A5321) and cdc14-3, rad52A (A12894) were taken at the indicated time points after
release and were assayed for the percentage of cells in anaphase. At least 50 anaphase
cells at each time point were scored for segregated nucleoli after release to determine the
percentage of cells in anaphase that had segregated nucleoli. Note that we did not score
the percentage of segregated nucleoli in anaphase cells in cdcl4-3 mutants at 90 minutes
after release, because very few anaphase cells were present at this time.
(B) Cells were arrested in G1 in YEPD with a-factor (5 [tg/ml) and released into the cell
cycle at 370 C. At indicated time points, the percentage of cells in anaphase and the
percentage of cells with segregated nucleoli was determined for cdc15-2 (A2596), cdcl5-
2, dnl4A (A12629), cdcl4-3 (A5321) and cdc14-3, dnJ4A (A12631).
(C) Cultures were incubated at 370 C for 140 minutes and samples were taken. Cells were
processed and nucleolar (Nopl) segregation in anaphase cells was determined for cdcl4-3
(A5321), cdcl5-2 (A2596), wild-type (A2587), cdcl4-3, radlA (A15651), cdc15-2,
radlA (A15652), radlA (A15653), cdc14-3, dnl4A (A12631), cdc15-2, dnl4A (A12629),
dnl4A (A12712), cdc14-3, rad52A (A12894), cdc15-2, rad52A (A12734), rad52A
(A12732), cdcl4-3 (A15677), dnl4A, rad52A (A15677), cdc15-2, dnl4A, rad52A
(A15673), dnl4A, rad52A (A15675), cdc14-3, dnl4A, radlA (A15669), cdc15-2, dnl4A,
radlA (A15670), dnl4A, radlA (A15672), cdcl4-3, radlA, rad52A (A15663), cdc15-2,
radlA, rad52A (A15665), radlA, rad52A (A15667), cdc14-3, radlA, dnl4A, rad52A
(A15679), cdc15-2, radlA, dnl4A, rad52A (A15680), radlA, dnl4A, rad52A (A15682).
Deletion of CFI1/NET1 partially suppresses the rDNA segregation defect of cdc14-3
mutants.
Cfil/Netl binds to the non-transcribed spacer (NTS) regions 1 and 2 found in each
rDNA repeat (17). There, the protein is required not only to hold the protein phosphatase
Cdc 14 in an inactive state (33, 43), but also for assembling rDNA silencing complexes as
well as for efficient Pol I transcription (17, 32, 36). Because deletion of CFI1/NET1
disrupts nucleolar organization (32, 36) we examined the segregation behavior of rDNA
GFP dots. Deletion of CFIJ/NET1 significantly ameliorated the segregation defect of the
rDNA GFP dots in cdcl4-3 mutants (Figure 3A, B). This rescue was not due to the
inactivation of CFI/NET1 suppressing the temperature sensitive cdcl4-3 allele (Figure
3C). It was, however, possible that rDNA segregation required lower levels of Cdc 14
activity than viability at 370 C. We therefore also examined the effects of deleting
CFI/NET1 in cells depleted for Cdc 14. The open reading frame of CDC14 was fused to a
ubiquitin-arginine-lacZ fusion (32) and cloned under the control of the glucose repressible
GALI-10 promoter (GAL-URL-CDC14). The fusion was efficiently depleted within one
hour in the presence of glucose (Figure 3D) and led to the accumulation of anaphase cells
with unsegregated rDNA loci (Figure 3E, F). Deletion of CFI1/NET1 allowed rDNA
segregation to occur more efficiently in Cdc 14-depleted cells (Figure 3F). Together these
results suggest that Cfil/Netl's role in nucleolar organization, chromatin structure and/or
rRNA transcription rather than its role in regulating Cdcl4 activity was responsible for
efficient rDNA segregation in cdcl4-3 cfil/netlA mutants.
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Figure 3: Deletion of CFI1/NET1 rescues the rDNA segregation defect
in cells lacking CDC14
(A) Examples of unsegregated (top) and segregated (bottom) rDNA GFP dots in
anaphase cells. GFP dots are shown in green and DNA in blue.
(B) cdcl4-3 (A14617), cdc15-2 (A9972), cdcl4-3, cfilA (A14619) and cdc15-2, cfilA
(A14620) all carrying rDNA GFP dots were incubated at 370 C for 140 minutes in YEPD
medium and anaphase cells were scored for segregation of the rDNA-GFP dots as
described in Materials and Methods.
(C) Serial dilutions of wild-type (A2587), cdcl4-3 (5321), cfilA (A1536) and cdcl4-3,
cfilA (A1665) strains grown on YEPD plates at 350 C for two days.
(D-F) Wild-type (A14615; closed squares), cfilA (A15714, open squares), GAL-URL-
3HA-CDC14 (A15713, closed circles), and GAL-URL-3HA-CDC14, cfilA (A15715,
open circles) cells all carrying rDNA GFP dots were incubated in YEPD media at 300 C
to repress production of Cdc 14. The efficiency of the Cdc 14 depletion was determined by
Western blot analysis using protein samples from GAL-URL-3HA-CDC14 (A15713) (D)
and GAL-URL-3HA-CDC14, cfilA (A15715) (D). Vphl was used as a loading control in
Western blot analysis. At least 50 cells at each indicated time point were counted to
determine the percentage of anaphase cells (E), which were defined as dumb-bell shaped
cells with fully segregated DAPI masses, as shown in Figure 2A. At least 50 of these
anaphase cells were counted to determine the percentage of segregated GFP dots in
anaphase cells at the designated times (F).
Inhibition of transcription allows rDNA segregation to occur in cdcl4-3 mutants.
CFI1/NET1 is responsible for establishing a specialized silent chromatin structure at
the rDNA. However, the silenced nature of this region is not likely to impose a need for
Cdc 14 on its segregation because neither deletion of the silencing factor SIR2 (3, 12, 34)
nor deletion of Setl and Dot l, components of Histone H3 methyltransferases, which
methylate Histone H3 on lysine 4 and lysine 79, respectively, affected rDNA segregation in
cdcl4-3 mutants (2, 3, 25) (Figure 4). We therefore considered the possibility that rRNA
transcription, which occurs throughout the cell cycle (10) and which requires CFI1/NET1
to occur efficiently (32) affected rDNA segregation.
Thiolutin is an efficient inhibitor of all three RNA polymerases in yeast, as
transcription is strongly inhibited 20 minutes after the addition of the drug (18). Treatment
of wild-type cells with thiolutin for 2 hours did not affect the segregation of rDNA GFP
dots (Figure 5A) but it significantly ameliorated the segregation of these GFP dots in
cdcl4-3 mutants. The segregation of rDNA GFP dots occurred almost to the same extent as
in wild-type cells (Figure 5A) indicating that transcription-dependent processes induce
linkages at the rDNA that impose a need for CDC14 on their segregation.
CDC14 has been shown to mediate rDNA segregation in a condensin dependent
manner (6, 37, 44) suggesting that these factors function in the same pathway to bring
about rDNA segregation. If this were true, the rDNA segregation defects observed in
condensin mutants should, like those of cdcl4-3 mutants, be ameliorated by thiolutin
treatment. Indeed, addition of thiolutin to temperature sensitive condensin mutants (ycs4-2)
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Figure 4: Inactivation of SET1 and DOT1 does not affect rDNA
segregation in cdcl4-3 mutants.
cdc15-2 (A2596), cdc15-2, setlA, dotlA, hmlA (A13908), cdcl4-3 (A5321) and cdc14-3,
setlA, dotlA, hmlA (A13902) cells were arrested in G1 in YEPD with a-factor (5 [tg/ml)
followed by release into fresh YEPD medium at 370C. Samples were taken at the indicated
time points to determine percentage of cells in anaphase (left panel) and percentage of cells
with the nucleolus/Nopl segregated (right panel). Note that setlA dotlA, also carried a
deletion in the HML locus to be able to arrest cells with a-factor.
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Figure 5: Inhibition of transcription by Thiolutin treatment rescues the
rDNA segregation defects.
(A) Wild-type (A14615) or cdcl4-3 (A14617) carrying rDNA-GFP dots were grown in
YEPD or YEPD containing DMSO (+DMSO) or YEPD containing Thiolutin (87[M;
+Thiol) at 370 C for 140 minutes. At least 50 anaphase cells were scored for segregation
of the rDNA-GFP dots as described in Materials and Methods.
(B) ycs4-1 cells with rDNA-GFP dots (A15096) were treated as described in (A) and at
least anaphase cells were scored for rDNA GFP dot segregation. Note that the ycs4-2
strain was analyzed at the same time as cells shown in (A).
led to the segregation of rDNA GFP dots in 60 percent of cells (Figure 5B). In contrast to
cdcl4-3 mutants, the rescue of the rDNA segregation defect of condensin mutants was
incomplete. This is likely due to the fact that chromosome segregation as a whole is
impaired in condensin mutants. Our results indicate that the rDNA segregation defects
observed in cdcl4-3 and ycs4-2 mutants are suppressed by the inactivation of transcription.
Inactivation of Pol I transcription suppresses the rDNA segregation defect of cdcl4-3
mutants.
Transcription of the 18S, 5.8S and 28S encoding rRNA transcript is mediated by
RNA polymerase I, whereas that of the 5S transcript is mediated by RNA Polymerase III.
To determine whether it was Poll-mediated transcription of rRNA rather than transcription
at other chromosomal loci that inhibited rDNA segregation in cdcl4-3 mutants, we created
a conditional allele of the Pol I subunit RPA135. The open reading frame of RPA135 was
fused to a ubiquitin-DHFR fusion known as "degron", which leads to degradation of the
fusion protein via the N-end rule pathway at 370 C (reviewed in 8). The fusion was then
placed under the control of the methionine repressible MET3 promoter allowing for the
rapid depletion of the fusion in the presence of methionine at 35C (Figure 6A). To
examine the effects of depleting Rpa135 on rDNA segregation in cdcl4-3 mutants we
arrested cells in S phase using the DNA replication inhibitor hydroxyurea and then released
cells into the cdcl4-3 block under Pol I-depleting conditions (in the presence of methionine
at 35°C). Cells also carried overexpressed ubiquitin ligase Ubrl responsible for N-end rule
mediated protein degradation (reviewed in 41) to more efficiently deplete cells of the Pol I
subunit.
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Figure 6: Depletion of Rpa135 allows rDNA segregation in cdc14-3
mutants.
cdcl5-2, GAL-UBR1, MET-Degron-FLAG-RPA135 (A14237; closed squares), cdcl4-3,
GAL-UBR1, MET-Degron-FLAG-RPA135 (A 15691; open diamonds), GAL-UBR1
(A15692; open squares), cdcl4-3, GAL-UBR1 (A15693; closed diamonds) cells all
carrying rDNA GFP dots were arrested for three-hours in S-phase using 10 mg/ml
hydroxyurea (HU arrest) in synthetic medium lacking methionine containing 2%
raffinose and 0.5% glucose at 250 C. These cells were then transferred into YEP media
containing 2% raffinose, 2% galactose, and 8mM methionine at 350 C with 10 mg/ml HU
for an additional 2 hours to deplete Rpa135. Cells were then released into prewarmed
YEPD medium containing 8mM methionine at 350 C (0 time point) and samples were
taken at the indicated time points.
(A) The depletion of Rpal35 was determined by Western blot analysis using protein
samples from cdcl5-2, GAL-UBR1, MET-Degron-FLAG-RPA135 (A14237; left panel)
and cdcl4-3, GAL-UBR1, MET-Degron-FLAG-RPA135 (A15691; right panel). Pgkl
was used as a loading control in western blot analysis (lower panels).
(B) The percentage of cells with metaphase (left panel) and anaphase (right panel)
spindles was determined using tubulin staining at indicated times after the release from
the second HU arrest.
(C) rDNA GFP dots (left panel) and Nop 1 (right panel) were scored for segregation in
anaphase cells at the designated time after release from the second HU arrest.
Rpa135 was depleted upon inhibition of RPA 135 transcription and transient overexpression
of the ubiquitin ligase (Figure 6A). Upon release from the HU block, cells progressed
through metaphase and entered anaphase irrespective of whether Rpa135 was present or not
(Figure 6B). We did however notice that anaphase spindles appeared fragile and frequently
broken in both strains at later time points. Importantly, segregation of rDNA GFP dots
occurred much more efficiently in cdcl4-3 mutants lacking Rpal35 than in cdcl4-3
mutants with an intact polymerase I (Figure 6C). Similar results were obtained when we
analyzed the segregation of the entire nucleolus using Nop 1 staining as a means of
visualizing the nucleolus (Figure 6C). We did note however that the fraction of cells that
had segregated the nucleolus as observed using an anti-Nop antibody was lower than that
that had segregated rDNA GFP dots. This is due to the fact that the segregation of Nopl
masses was only scored when two clearly distinct Nop 1 positive masses of equal size were
present in cells with intact anaphase spindles. In contrast, rDNA GFP dots were considered
segregated when the two GFP dots were separated to opposite ends of the bi-lobed nucleus,
which also occurs in cells where the nucleolus has not yet completely partitioned. Our
findings indicate that rRNA transcription antagonizes rDNA segregation in cdcl4-3
mutants. The finding that Nop staining remained intact during the anaphase following the
depletion of RPA135 furthermore not only indicates that inhibiting rRNA transcription does
not immediately lead to disassembly of all nucleolar structures, but also implies that the
nucleolus itself, at least as defined by Nop staining, is not the reason why this
chromosomal region requires CDC14 for its segregation.
Discussion
In budding yeast, the rDNA and the genomic regions distal to the rDNA locus on
chromosome XII segregate late during mitosis and require the protein phosphatase CDC14
to do so (6, 37, 40, 44). This requirement is not simply due to the length of the
chromosomal arm carrying the rDNA array (1-2 Mb) because a chromosome XII carrying a
short array of rDNA repeats (25 copies) also requires CDC14 for its segregation.
Conversely, a dramatic increase in repeat number did not worsen rDNA segregation in
wild-type or cdcl4-3 cells. We therefore conclude that rDNA transcription-dependent
processes induce a novel type of linkage that holds this specialized genomic region
together. Furthermore, resolution of these transcription based linkages need specialized
pathways, such as the FEAR network-Cdc 14-condensin pathway.
Previous studies and the findings presented here indicate that several types of
linkages exist at the rDNA. Cohesins hold the rDNA together until their removal at the
metaphase - anaphase transition. Inactivation of cohesins, however, does not eliminate the
need of CDC14 in rDNA segregation indicating that additional mechanisms exist that hold
the duplicated rDNA together (6). Recombination or rDNA silencing do not appear to
create linkages at the rDNA (6, 37). Furthermore, the repetitiveness of the rDNA locus per
se does not appear to affect segregation, at least in the range examined here. A 25 repeat
rDNA array segregates as poorly as, if not worse than, a 150 repeat array. We note,
however, that this result does not exclude the possibility that a certain minimal number of
repeats is necessary for rDNA linkages to be established that need CDC14 for their
segregation but our results nevertheless argue against repetitiveness being mainly
responsible for establishing rDNA linkages.
Our data not only exclude silencing, recombination and - to some extent -
repetitiveness as the source of linkages at the rDNA that need CDC14 for their resolution,
but also implicate rRNA transcription and/or processes dependent on it. Reducing the
efficiency of rRNA transcription by the deletion of CFI/NET1 or by complete elimination
of rRNA transcription by thiolutin treatment or by the inactivation of RNA Polymerase I
allows cdc14-3 mutants to segregate their rDNA with an efficiency close to that seen in
cdcl5-2 mutants, which arrest in anaphase with their rDNA segregated. The rescue was
nearly complete when cells were treated with thiolutin and significant when Rpa135 was
depleted from cells. Although the fact that the rescue was less efficient in Rpal35-depleted
cells than in thiolutin-treated cells is likely due to the incomplete depletion of Rpal35, we
cannot exclude the possibility that either Pol III-mediated transcription of the 5S RNA
contributes to the cohesiveness of the rDNA or that Cdc 14 has additional roles in
promoting rDNA segregation. The fact that rDNA repeat length does not significantly
affect rDNA segregation in cdc14-3 mutants is also consistent with rRNA transcription
preventing rDNA segregation. rRNA transcription at each individual repeat is increased
when the number of repeats is reduced (11). Conversely, when the number of rDNA
repeats is increased, it is possible that transcription of each individual rDNA repeat is
decreased (27).
What do we know about the nature of these rDNA transcription-dependent
linkages? They appear to be specific to the rDNA locus. The presence of a heavily
transcribed gene (a gene transcribed from the strong GALI-IO promoter) elsewhere in the
genome does not affect the segregation of a neighboring tetO array (BNT, unpublished
observations). However, they are not specific to Pol I-mediated transcription. Cells in
which rRNA is transcribed by polymerase II also require CDC14 for the segregation of the
rDNA. rRNA transcription could induce a local increase in catenation, which needs special
pathways for resolution. In this scenario, the segregation defects of telomeric sequences
observed in cdcl4-3 mutants (6) could be a consequence of transcription-induced
catenation events pushed towards the ends of chromosomes during chromosome
segregation. We favor the idea that rRNA transcripts themselves and/or factors that
assemble onto them (26) establish linkages at the rDNA. EM studies of spreads of yeast
rDNA genes (aka Miller Spreads) provide a glimpse as to the amount of rRNA and rRNA
binding proteins being concentrated at the rDNA (11, 28, 30). Protein complexes such as
the large U3 snoRNP-containing complex called the SSU processome, which is required
for the cleavage and maturation of the 18S rRNA (9), assembles in a step-wise manner onto
rRNA co-transcriptionally (28). This result also implies that rRNA modifications, which
are generally thought to occur prior to cleavage also occur co-transcriptionally. While our
results imply transcription-dependent processes in establishing linkages between the sister
rDNA loci, they argue against the nucleolus itself, whose assembly depends on rRNA
transcription (26), imposing a need for CDC14 on rDNA segregation. Upon inactivation of
RPA135, the nucleolus did not disassemble at least as judged by Nop staining but rDNA
segregation occurred nevertheless efficiently in cdcl4-3 mutants. A model in which the
simple presence of many proteins assembled around the rDNA affect its segregation is thus
unlikely.
rRNA synthesis is continuous throughout the cell cycle in yeast (10). It is thus not
surprising that specialized mechanisms exist that dissolve these linkages. At least one such
mechanism involves the protein phosphatase Cdc 14 and condensin. Inhibition of rRNA
transcription suppressed the rDNA segregation defect of cdcl4-3 and condensin mutants
indicating that rRNA-induced linkages either act in parallel to those targeted by the
phosphatase and condensin or are the linkages resolved by Cdc 14-mediated processes. We
favor the latter possibility because the rDNA segregation defect of cdcl4-3 mutants is
substantially, if not completely rescued by the elimination of rDNA transcription, arguing
for a linear relationship between these two events. How could condensin and CDC14
dissolve transcription-mediated connections between sister rDNA loci? Perhaps condensin
targeted to the rDNA by Cdcl4 individualizes DNA strands through its condensation
function or organizes the rDNA repeats in a way that rRNA transcripts and factors that
assemble onto them no longer interfere with segregation. It is also possible that Cdc 14 and
condensin induce changes in the nucleolar structures that facilitate its segregation and that
of the DNA it embeds. Animal cells appear to employ a different strategy to resolve
transcription-induced rDNA linkages. In these systems, rRNA transcription and ribosome
biogenesis are shut down and the nucleolus is disassembled prior to the onset of mitosis
(reviewed in 39). It thus appears that the different eukaryotes have evolved different
strategies to resolve transcription induced linkages.
Materials and Methods
Strains and plasmids
All strains are isogenic with strain W303 (K699) and are listed in Table 1. Unless
stated otherwise, gene deletions were constructed through one-step PCR as described
(22). NOY1071 was used to make strain A14628 and NOY794 was used to make strain
A14742, and A14743 (11, 27). rDNA-GFP dot strains were made as described
previously (6). The MET-DHFRts-FLAG construct, which was employed to generate a
conditional depletion allele of RPA135 was made by cloning the MET promoter in front
of the previously described DHFR-ts Degron construct and by fusing the FLAG epitope
to DHFR (8). This construct was then integrated upstream of the RPA135 open reading
frame using a PCR based strategy. pGAL-URL-CDC14 was made by integrating pGAL-
URL-3HA upstream of the CDC14 gene by a PCR based strategy. The pGAL-URL-3HA
fusion was constructed from the previously described pWS 103 plasmid containing the
UPL degron (32).
Growth Conditions
Strains were grown to log phase at 250 C in media specified in the Figure legends
and arrested in G1 using a final concentration of 5mg/ml a-factor as described previously
(6). 2.51pg/ml a-factor was added to all cultures again two hours later to prevent escape
from the arrest. Strains were grown to log phase at 250 C in the media specified in the
Figure legends and arrested in S-phase using 10 mg/ml hydroxyurea as described
previously (reviewed in 1). If hydroxyurea arrest was longer than two hours, 5 mg/ml
hydroxyurea was re-added to all cultures to prevent escape from the arrest. Thiolutin
(CMS Chemicals Ltd) was dissolved in DMSO (Fluka Chemicals) and used at a final
concentration of 87[tM (18).
Other techniques
Indirect immunofluorescence on whole cells was carried out as described
previously (43). Immunofluorescence samples were visualized using a Zeiss Axioplan 2
microscope. Unless noted otherwise, 100 cells were scored for each time point. Rat a-
tubulin antibodies (Oxford Biotechnology) and fluorescein isothiocyanate-conjugated a-
rat antibodies (Jackson ImmunoResearch) were both diluted at 1:500. Mouse a-Nopl
(EnCor Biotechnology Inc) and Cyanine Cy3-conjugated a-mouse (Jackson
ImmunoResearch) antibodies were diluted at 1:750 and 1:1000, respectively.
Anaphase cells were defined as cells with an elongated mitotic spindle and two
distinct DAPI masses. Segregated nucleoli were defined as anaphase cells with two
distinct and unconnected Nop masses of approximately equal size. Detection of rDNA-
GFP dots was performed as described (6). To score rDNA-GFP segregation in anaphase
cells, a cell was defined as being in anaphase if it was a dumb-bell shaped cell with fully
segregated DAPI masses. These anaphase cells were scored for either unsegregated
rDNA-GFP dots (one rDNA dot total) or segregated rDNA-GFP dots (two rDNA dots
total; one dot per nuclear lobe). The percent of anaphase cells with segregated rDNA-
GFP dots was calculated by dividing the number of anaphase cells with segregated rDNA
GFP dots by the number of anaphase cells with segregated and unsegregated GFP dots.
The small percentage of anaphase cells with two distinct GFP dots that had not yet
segregated to opposite lobes of the cell were not included in these calculations, because
they fit neither into the fully segregated nor unsegregated category.
Western blot analysis was performed as previously described (42). Mouse anti-
flag antibodies (Sigma) were used at 1:625, mouse anti-Pgkl antibodies (Molecular
Probes) were used at 1:25,00, mouse anti-Vphl antibodies (Molecular Probes) were used
at 1:2000, mouse anti-HA (HA-11; Covance) was used at 1:1000, and anti-mouse HRP
(Amersham) antibodies at 1:2000 or 1:5000.
Table 1: Strains used in this study
Strain Relevant genotype
A1536 MATa, cfil:: URA3
A1665 MATa, cfil::URA3, cdcl4-3
A2587 MATa (wild-type)
A2596 MATa, cdcl5-2
A5321 MATa, cdcl4-3
A9972 MA Ta, cdcl5-2, PURA3::tetR::GFP::LEU2, RDN1::tetOxll2:: URA3
A10676 MATa, cdc14-3foblA::HIS3
A12629 MATa, cdcl5-2, dnl4A::TRP1
A12631 MATa, cdcl4-3, dnl4A::TRP1
A12712 MATa, dnl4A::TRP1
A12732 MATa, cdcl5-2, rad52A::TRP1
A12734 MATa, cdcl5-2, rad52A::TRP1
A12894 MATa, cdcl4-3, rad52A::TRP1
A13902 MATa, setlA::kanMX6, dotlA::TRPJ, hmlA::LEU2, cdcl4-3
A13908 MATa, setlA::kanMX6, dotlA::TRP1, hmlA::LEU2, cdcl5-2
A14237 MATa, Pura3::tetR::GFP::LEU2, RDNl::tetOxll2::URA3, cdcl5-2,
UBRI: GAL- Ubi-M-lacl-frag-Myc- UBRJ::HIS3, CaURA3MX6-Degron-
FLA G-RPA 135
A14615 MATa, PURA3::tetR::GFP::LEU2, RDN1::tetOxll2::URA3
A14617 MATa, cdcl4-3, PURA3::tetR::GFP::LEU2, RDN1::tetOxll2::URA3
A14619 MATa, cdcl4-3, cfilA::HIS5, PURA3::tetR::GFP::LEU2,
RDN1::tetOx112:: URA3
A14620 MATa, cdc15-2, cfilA::HIS5, PURA3::tetR::GFP::LEU2,
RDN ::tetOxl l 2:: URA3
A14628 MATa, cdcl4-3foblA::HIS3, 25xRDN1
A14742 MATa, rpa35A, rrn9A , PURA3::tetR::GFP::LEU2,
RDN1::tetOxl12:: URA3
A14743 MATa, rpal35A, rrn9A , cdcl4-3, PURA3::tetR::GFP::LEU2,
RDNI::tetOx 12:: URA3
A15651 MATa, cdcl4-3, radlA::kanMX
A15652 MATa, cdcl5-2, radlA::kanMX
A15653 MATa, radl A::kanMX
A15663 MATa, cdcl4-3, radlA::kanMX, rad52A::TRP1
A15665 MATa, cdc15-2, radlA::kanMX, rad52A:: TRP1
A15667 MATa, radlA::kanMX, rad52A::TRP1
A15669 MATa, cdcl4-3, radlA::kanMX, dnl4A::TRP1
A15670 MATa, cdcl5-2, radlA::kanMX, dnl4A::TRP1
A15672 MATa, radlA::kanMX, dnl4A::TRP1
A15673 MATalpha, cdcl5-2, dnl4A::kanMX, rad52A::TRP1
A15675 MATa, dnl4A::kanMX, rad52A::TRP1
A15677 MATa, cdcl4-3, dnl4A::kanMX, rad52A::TRP1
A15679 MATa, cdcl4-3, radlA::kanMX, dnl4A::TRP , rad52A::TRP1
A15680 MATalpha, cdc15-2, radlA::kanMX, dnl4A::TRP , rad52A::TRP1
A15682 MATa, radlA::kanMX, dnl4A::TRP1, rad52A::TRP1
A15691 MATa, Pura3::tetR::GFP::LEU2, RDN1::tetOx112::URA3, cdcl4-3,
UBRI ::GAL-Ubi-M-lacl-frag-Myc-UBR ::HIS3, CaURA3MX6-Degron-
FLA G-RPA 135
A15692 MATa, Pura3::tetR::GFP::LEU2, RDN1::tetOxll2::URA3, UBRI::GAL-
Ubi-M-lacI-frag-Myc-UBR ::HIS3
A15693 MATalpha, Pura3::tetR::GFP::LEU2, RDNI::tetOxll2::URA3,
UBRI::GAL- Ubi-M-lacl-frag-Myc-UBR1::HIS3, cdcl4-3
A15713 MATa, cdcl 4::GAL-URL-3HA-CDC14::kanMX,
PURA3::tetR::GFP::LEU2, RDN1::tetOxl 12:: URA3
A15714 MATa, cfiJA::HIS5, PURA3::tetR::GFP::LEU2, RDN1::tetOxll2::URA3
A15715 MATa, cdcl4::GAL-URL-3HA-CDC14::kanMX, cfilA::HIS5,
PURA3::tetR::GFP::LEU2, RDN1::tetOxll2::URA3
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Chapter III
Examining the functional significance and protein regulators
of Spol2 phosphorylation
Summary
In budding yeast, the essential phosphatase Cdcl4 is activated to regulate mitotic
exit through dissociation from its inhibitor Cfil/Netl in the nucleolus. By inducing the
release of Cdc 14 from the nucleolus during anaphase, two signaling networks, the Cdc
fourteen early anaphase release (FEAR) network and the mitotic exit network (MEN)
allow Cdc 14 to access important mitotic substrates necessary for inactivation of mitotic
cyclin dependent kinases (CDKs). One FEAR network component, Spo 12, has been
shown to be phosphorylated on two serines in the conserved C-terminal domain. We
demonstrate that phosphorylation of Spo 12 peaks in anaphase and is required for the
FEAR network function of Spo 12. Unlike the MEN, components of the FEAR network
are required for Spol2 phosphorylation in anaphase. Additionally, Spol2
phosphorylation is Cdc28-dependent, whereas Cdcl4 is needed for Spol2 de-
phosphorylation throughout the cell cycle. Our results demonstrate that Spol2
phosphorylation by CDKs is essential for the FEAR network mediated Cdcl4 release
from the nucleolus.
Introduction
The careful orchestration of cell cycle events by the activity of CDKs is necessary
to maintain proper genomic stability. In the budding yeast Saccharomyces cerevisiae,
mitotic CDKs persist until anaphase and must be inactivated to allow exit from mitosis
and entry into the next cell cycle. The conserved phosphatase Cdcl4 is required to
induce CDK inactivation in anaphase (28). Held sequestered in the nucleolus throughout
most of the cell cycle, Cdc 14 must be released from its inhibitor Cfil/Net in order to
reach substrates necessary for CDK inactivation (29). During anaphase, two signaling
networks, the FEAR network and the MEN induce the release of Cdcl4 from Cfil/Netl
in the nucleolus, allowing Cdcl4 to access and dephosphorylate mitotic substrates (21).
The FEAR network functions in early anaphase and includes the polo-like kinase Cdc5,
the protease Espl, the kinetochore protein Slkl9, the nuclear protein Spo 12, and the
replication fork block protein Fob 1 (23). Recently the PP2A regulatory subunit Cdc55
was shown to be an inhibitor of the FEAR network (16). Cdcl4 released by the FEAR
network dephosphorylates targets that contribute to spindle stability, allows for the proper
segregation of specialized genomic regions such as the rDNA and telomeres, and
contributes to the activation of the MEN (4, 8, 21, 24, 26, 32). The MEN resembles a
Ras-like GTPase signaling cascade. Components of the MEN include the scaffold
protein Nud , the GTPase Teml 1, the two component GTPase activating protein (GAP)
Bub2-Bfal, the putative guanine nucleotide exchange factor (GEF) Ltel, the protein
kinases Cdcl5, Dbf2, and Cdc5, and the Dbf2 activating protein Mobl (5). The MEN
signals the release of Cdcl4 from the nucleolus in late anaphase, which allows Cdcl4 to
enter the nucleus and cytoplasm to promote CDK inactivation through dephosphorylation
of Sicl, Swi5 and Cdhl (28). Dephosphorylation of the transcription factor Swi5 allows
it to enter the nucleus and upregulate the transcription of the CDK inhibitor SIC1.
Cdhl/Hctl dephosphorylation by Cdcl4 activates Cdhl such that it contributes to mitotic
cyclin degradation. The activity of Cdc 14 not only contributes to the inactivation of
mitotic CDKs, but Cdc 14 also counteracts their effects by directly targeting CDK
substrates for dephosphorylation.
Phosphorylation events also control the timing of the release of Cdc 14 from its
inhibitor because Cfil/Netl, Spo 12, Bub2/Bfal, the kinases of the MEN, and Cdcl4 have
all been shown to be phosphorylated (21). Currently, it is thought that Cdcl4 dissociates
from Cfil/Netl in early anaphase due to phosphorylation of Cfil/Netl and Cdc 14, which
may destabilize their interaction. Recent work suggests that Cdc55 normally functions to
keep Cfil/Netl under-phosphorylated by counteracting the activity of Cdc28, the
budding yeast CDK (1, 16). However at the metaphase to anaphase transition, Esp 1 is
activated and downregulates PP2A/Cdc55 activity (16). This allows Cdc28 to
phosphorylate Cfil/Netl, contributing to its release of Cdc 14 from the nucleolus in early
anaphase (1). Although Cfil/Netl is highly phosphorylated in MEN mutants such as
cdcl5-2, this is not sufficient to maintain Cdc14 in its released state (21). Therefore,
there are likely to be other factors contributing to driving the release of Cdc 14 besides
phosphorylation of Cfil/Netl.
We show here that phosphorylation of Spo 2 in early anaphase is another factor
contributing to regulating the timing and localization of Cdcl4 activity. Through the use
of a newly developed phospho-specific antibody against phosphorylated serine 118 on
Spo 12, we investigate the functional significance and regulation of Spo 12
phosphorylation during exit from mitosis. Previous work showed that S 118 and S 125
phosphorylation on Spo 2 are required for function (22). We show that phosphorylation
of Spo 12 is required for the FEAR network function of Spo 12, and accordingly, Spol2
phosphorylation occurs only in anaphase. The MEN does not regulate Spol2
phosphorylation, but the FEAR network components Slkl9 and Espl are required for
Spol2 phosphorylation in anaphase. Like Cfil/Netl phosphorylation, Spol2
phosphorylation is dependent on Cdc28 (1). However, loss of CDC55 does not rescue
the absence of Spol2 phosphorylation in espl-1 cells, indicating that Cdc55 is not
downstream of Espl, at least for Cdc28-dependent Spol2 phosphorylation. We also
examined the role of Cdcl4 in Spol2 phosphorylation. Cdcl4 promotes the
dephosphorylation of Spo 12, not just in anaphase, but also throughout the cell cycle,
raising the interesting possibility that active pools of Cdc 14 reside in the nucleolus. Our
results suggest that Spo 12's promotion of Cdc 14 release is restricted to anaphase through
the regulation of Cdc28 promoting Spol2 phosphorylation and Cdcl4's competing
dephosphorylation activity towards Spo 12.
Results
Spol2 phosphorylation is required for Spol2's FEAR network function
Spo 12 was previously shown to be phosphorylated on two conserved C-terminal
serines, serine 118 (S118) and serine 125 (S125) (22). 32P incorporation into Spol2 is
drastically reduced upon mutation of these two phosphorylated serines to alanines
(S 118A, S125A, referred to henceforth as SSAA) in Spol2 (22). This result argues that
S 118 and S125 are the main sites of phosphorylation within Spol2. In order to determine
if Spo12 phosphorylation is important for its function, endogenously expressed Spo 12
single (S 118A or S 125A) and double SSAA Spol2 phospho-mutants were examined for
Spol2 function. Mutating the main two sites of phosphorylation in Spo 2 did not affect
protein stability and the protein remained properly localized to the nucleus and nucleolus
(Figure lA). However, spol2-SSAA cells displayed a mitotic exit delay of 10-15
minutes, characteristic of FEAR network mutants (Figure 1B, 22). Also like spol2A
cells, S118A, S125A, and SSAA Spol2 phospho-mutants were unable to rescue the
lethality of spol2A ItelA double mutants (Figure 1C). This data corroborates the
previous observation that over-expression of spol2-SSAA does not rescue the temperature
sensitive lethality of cdc15-2 mutants as does overexpression of wild type SP012 (19,
22). Spol2 phospho-mutant strains also behave like spol2A cells in meiosis, as S118A,
S125A, and SSAA mutants all form dyads, but never tetrads (Figure ID, 19). Our results
suggest that the phosphorylation of Spo 12 is required for its function to induce the FEAR
network release of Cdc 14 from the nucleolus.
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Figure 1: Spol2 phosphorylation is required for Spol2 FEAR network
function
(A and B) SP012-13MYC (A4568; 0) and spol2-SSAA-13MYC (A21789; 0) cells were
arrested in GI with a-factor (5[tg/mL) at 250 C and released into fresh medium as
described in Experimental Procedures. Spol2 protein levels were determined by Western
blot analysis at the indicated times after release (A, top panels) as described in
Experimental Procedures. v-ATPase was used as a loading control in Western blot
analysis (A, lower panels). The percentage of cells in metaphase (open shapes) and
anaphase (closed shapes) was determined using tubulin staining at indicated times after
release (B).
(C) Serial dilutions of spol2A, ItelA, pLTE1-URA3 cells with SP012-13MYC (A21779),
spol2-SSAA-13MYC (A21780), spol2-S118A-13MYC (A21782), or spol2-S125A-
13MYC (A21784) strains grown on yeast extract-peptone-dextrose (YEPD) plates (left
panel) or YEPD + 5-Fluorootic Acid (5-FoA) plates (right panel) at 300C for 3 days.
(D) SP012-13MYC (A21797), spol2A (A21798), spo12-S118A-13MYC (A21799),
spo12-S125A-13MYC (A21800), and spol2-SSAA-13MYC (A21801) diploid cells were
induced to sporulate. After 48 hours, DNA was stained with 4'-6-Diamidino-2-
phenylindole (DAPI) to determine the percentage of dyad and tetrad cells.
Spol2 phosphorylation is maximal in anaphase.
To determine the importance of Spo 12 phosphorylation, a rabbit antibody specific
to Spo 12 phosphorylated on S 118 was generated (henceforth, Spo 12 phospho-antibody;
refer to Experimental Procedures for details). Antibodies created to recognize
phosphorylated S125 on Spo 12 were not specific, and were therefore unable to be used
for further analysis. However, the S118 antibody was confirmed to be specific to
phosphorylated S118 on Spo 12, as the antibody can recognize Spo 12 in cells over-
expressing either wild type SP012 or spol2-S125A, but cannot recognize over-expressed
spol2-S118A (Figure 2A). Synchronous culture experiments revealed that Spol2
phosphorylation is cell cycle regulated, as Spo 2 phosphorylation is observed when the
cells are in anaphase (Figure 2B).
To confirm the observation that Spo 2 phosphorylation peaks in anaphase and our
previous results are not an artifact of SPO12 overexpression, we synchronized wild type
cells expressing SP012 from its endogenous promoter in GI and then released these cells
into the cell cycle. In order to detect phosphorylation of Spol2, Spol2-13MYC was
immunoprecipitated in samples throughout the cell cycle. In wild type cells,
phosphorylation of Spo 12 on S118 is not seen until the cells enter anaphase (Figure 2C
and 2D). Additionally, Spol2 phosphorylation is lost as the cells exit from mitosis
(Figure 2C and 2D).
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Figure 2: Spol2 phosphorylation is maximal in anaphase
(A and B) GAL-SPO12-13MYC (A18282; U) GAL-spol2-S125A-13MYC (A7084; 0)
GAL-spol2-S118A-13MYC (7080; -a) cells were grown in YEPR medium and arrested
in GI with a-factor (5[tg/mL) at 250 C. Expression of Spol2 was induced 2 hr prior to
release by addition of 2% galactose, and cells were released into galactose-containing
medium. Anti-pS 118-Spo 12 was used to detect phosphorylated Spo 12 by Western blot at
indicated time points after release (A, top panels). Spo 12 protein levels were determined
by Western blot analysis at the indicated times after release (A, middle panels). Pgkl
was used as a loading control in Western blot analysis (A, lower panels). The percentage
of cells in anaphase was determined using tubulin staining at indicated times after release
(B).
(C and D) SP012-13MYC (A4568) cells were arrested in GI with a-factor (5[tg/mL) at
250 C and released into fresh medium. Spol2 protein was immunoprecipitated at each
time point after release. Western blot analysis on immunoprecipitate was done to detect
phosphorylated Spol2 (C, top panel) and total Spo 12 protein (C, lower panel) as
described in Experimental Procedures. The percentage of cells in metaphase (0) and
anaphase (0) was determined using tubulin staining at indicated times after release (D).
Spo 12 is not evenly expressed throughout the cell cycle, as protein levels peak
during mitosis (Figure lA; 7, 19, 22). Since Spol2 phosphorylation also peaks in
anaphase, it can be difficult to determine if the increase in Spo 12 phospho-signal is due to
increased phosphorylation or simply reflects higher protein levels. Therefore, to
effectively determine if Spo 12 phosphorylation changes during the cell cycle, it was
important to immunoprecipitate equal amounts of Spo 12 protein across the cell cycle. To
accomplish this, Spo 2 protein levels were determined in the immunoprecipitated
samples from each experiment by Western blot using the anti-myc-HRP antibody (Figure
3, top panel). Based on these measurements, the amount of immunoprecipitated material
loaded in the subsequent Western blot was adjusted so that equal amounts of Spol2 are
present at each time point (Figure 3, middle panel). Loading more immunoprecipitated
material in time points with low Spo 12 levels also increases the intensity of the lower
non-specific band when the Spol2 phospho-antibody is used for detection (Figure 3,
bottom panel; noted with an asterisk where present in Figures). All subsequent
experiments to assess Spo 2 phosphorylation were also done this way. This method
demonstrates that Spo 2 phosphorylation in anaphase is specific and not a consequence
of different amounts of Spo 12.
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Figure 3: Normalizing Spol2 levels across the cell cycle
SPO12-13MYC cells were arrested in S phase with hydroxurea and released into fresh
medium at 250 C as described in Experimental Procedures. Spol2 protein was
immunoprecipitated at each indicated time point after release. Immunoprecipitated
Spol2 protein levels were detected by Western blot analysis (A, top panel). To
normalize Spo 12 immunoprecipitate levels across the cell cycle, another Western blot
was run loading more sample in the earliest and latest time points. This Western blot was
probed for phosphorylated Spo 12 (A, bottom panel) and Spo 12 protein levels (A, middle
panel). A lower non-specific band is noted with an asterisk. The percentage of cells in
metaphase and anaphase was determined using tubulin staining at indicated times after
release (B).
Spol2 phosphorylation is not dependent on the MEN
Having established a protocol for effectively examining Spo 12 phosphorylation,
we wanted to determine if the MEN is required for Spo12 phosphorylation. cdcl5-2
mutants were arrested in metaphase using nocodazole and released synchronously into
the cell cycle at the restrictive temperature to inactivate the cdclS5-2 gene product. Spo12
phosphorylation is seen as cdcl5-2 cells enter anaphase, just as is the case in wild type
cells (Figure 4A). Whereas wild type cells exit from mitosis and lose Spol2
phosphorylation, cdcl5-2 cells arrest in anaphase and Spol2 phosphorylation remains
high (Figures 4A and 4B). Neither Dbf2 nor Teml activity are required for Spol2
phosphorylation, as Spol2 phosphorylation in dbJ2-2 and teml-3 cells is the same as in
cdcl5-2 cells (data not shown). Cdc5 function is also not required for Spol2
phosphorylation, as indicated by the appearance of Spo 12 phosphorylation as cdc5-1
mutant cells enter anaphase (Figures 4C and 4D). Our results indicate that MEN function
is not required for Spol2 phosphorylation.
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Figure 4: Spol2 phosphorylation is not dependent on the Mitotic Exit
Network
(A and B) SP012-13MYC (A4568;0) and cdcl5-2 SP012-13MYC (A5170;O) cells
were arrested in metaphase at 250 C using nocodazole and released into fresh medium at
370 C as described in Experimental Procedures. Spol2 protein was immunoprecipitated
at each time point after release. Western blot analysis on immunoprecipitate was done to
detect phosphorylated Spol2 (A, top panels) and total Spol2 protein (A, lower panels).
The percentage of cells in metaphase (open shapes) and anaphase (closed shapes) was
determined using tubulin staining at indicated times after release (B). As noted in
Experimental Procedures, spindles must recover from nocodazole treatment before intact
spindles can be visualized and scored.
(C and D) SPO12-13MYC (A4568; O) and cdc5-1 SPO12-13MYC (A 18461;O) cells
were arrested in GI with a-factor (51tg/mL) at 250 C and released into fresh medium at
370 C. Spol2 protein was immunoprecipitated at each time point after release. Western
blot analysis on immunoprecipitate was done to detect phosphorylated Spol2 (C, top
panels) and total Spol2 protein (C, lower panels). The percentage of cells in metaphase
(open shapes) and anaphase (closed shapes) was determined using tubulin staining at
indicated times after release (D).
Spol2 phosphorylation is dependent on the FEAR network components Slkl9 and
Espl
Next we determined whether the FEAR network was needed for Spo 12
phosphorylation. Spol2 phosphorylation was dramatically reduced in slkl9A cells
progressing through the cell cycle in a synchronous manner, indicating that Slkl9 is
important for Spol2 phosphorylation (Figures 5A and 5B). The levels of Spol2
phosphorylation were also examined in an espl-1 mutant. MAD] was deleted in these
cells to avoid any possible effects caused by activation of the spindle checkpoint, which
inhibits the metaphase to anaphase transition until all the chromosomes are properly
attached to the mitotic spindle (15). In cdcl5-2 madlA cells, Spol2 is phosphorylated
within 70 minutes of being released from a GI arrest into 370 (Figures 5C and 5D).
However, in cdcl5-2 espl-1 madlA cells, Spol2 phosphorylation was not seen during the
220-minute duration of the experiment (Figures 5C and 5D). These data indicate that the
Slkl9/Espl branch of the FEAR network is needed for Spo 12 phosphorylation in
anaphase.
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Figure 5: Slkl9 and Espl are required for Spol2 phosphorylation in
anaphase
(A and B) cdcl5-2 SP012-13MYC (A5170;1O) and cdc15-2 slkl9A SPO12-13MYC
(A19359;O) cells were arrested in metaphase at 250 C using nocodazole and released into
fresh medium at 370 C as described in Experimental Procedures. Spol2 protein was
immunoprecipitated at each time point after release. Western blot analysis on
immunoprecipitate was done to detect phosphorylated Spo 12 (A, top panels) and total
Spol2 protein (A, lower panels). The percentage of cells in metaphase (open shapes) and
anaphase (closed shapes) was determined using tubulin staining at indicated times after
release (B). As noted in Experimental Procedures, spindles must recover from
nocodazole treatment before intact spindles can be visualized and scored.
(C and D) cdcl5-2 madlA SPO12-13MYC (A19220;O) and cdcl5-2 madlA espl-1
SP012-13MYC (A19204;O) cells were arrested in G1 with a-factor (5p[g/mL) at 250 C
and released into fresh medium at 370 C. Spol2 protein was immunoprecipitated at each
time point after release. Western blot analysis on immunoprecipitate was done to detect
phosphorylated Spol2 (C, top panels) and total Spol2 protein (C, lower panels). The
percentage of cells in metaphase (open shapes) and anaphase (closed shapes) was
determined using tubulin staining at indicated times after release (D).
Cdc55, a regulatory subunit of the PP2A phosphatase, has been shown to be a
negative regulator of the FEAR network (16). Recently published work suggests that
Cdc55 normally functions to prevent Cfil/Netl from being phosphorylated by Cdc28 (1,
16). The proposed model is that upon Esp activation at the metaphase to anaphase
transition, Espl downregulates PP2A/Cdc55 activity, which allows Cfil to exist in a
hyper-phosphorylated state, contributing to its release of Cdcl4 from the nucleolus in
early anaphase (1, 16). Knowing that Esp is required for Spol2 phosphorylation, we
were therefore surprised to see that deletion of CDC55 did not change either the extent or
kinetics of Spo 12 phosphorylation (data not shown). If the main role of Esp 1 in the
FEAR pathway is to inactivate Cdc55, then loss of CDC55 would have been expected to
have some affect on Spol2 phosphorylation. Our results would be consistent with Cdc55
functioning upstream of or in parallel to Esp 1 in the FEAR pathway, instead of
downstream. Therefore, we decided to re-examine the ordering of Cdc55 within the
FEAR pathway by determining the effect of losing both CDC55 and Esp 1 activity on
Spol2 phosphorylation. Like espl-1 cells, cdc55A espl-1 double mutant cells do not
show Spol2 phosphorylation (Figures 6A and 6B). This argues that Cdc55 is likely to be
functioning upstream of or in parallel to the role of Esp 1 in the FEAR pathway. We can
also not rule out the formal possibility that Espl also activates the FEAR network and
Spol2 phosphorylation in ways not affected by Cdc55 (see Discussion).
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Figure 6: cdc55A does not rescue loss of Spol2 phosphorylation
in espl-1 cells
cdcl5-2 madlA SP012-13MYC (A19220;O), cdcl5-2 madlA espl-1 SP012-13MYC
(A19204;O) and cdcl5-2 madlA espl-1 cdc55A SP012-13MYC (A20967; 0) cells were
arrested in GI with a-factor (5[tg/mL) at 250 C and released into fresh medium at 370 C.
Spol2 protein was immunoprecipitated at each time point after release. Western blot
analysis on immunoprecipitate was done to detect phosphorylated Spol2 (A, top panels)
and total Spo 12 protein (A, lower panels). The percentage of cells in metaphase (open
shapes) and anaphase (closed shapes) was determined using tubulin staining at indicated
times after release (B).
Previous studies showed that the nucleolar protein Fob interacts with Spol2 and
negatively regulates the FEAR release of Cdc 14 (22). Fob may be countering the FEAR
release of Cdc 14 by negatively regulating Spo 12 phosphorylation. However, deletion of
FOB] did not alter the levels of Spol2 phosphorylation (Figure 7A). Additionally,
deletion of FOB] did not affect the timing of Spo 12 phosphorylation as in both wild type
andfoblA cells phosphorylation peaks at the same time as anaphase (Figures 7A and 7B).
Overexpression of FOB] delays both mitotic exit and Cdcl4 early anaphase release and
hinders Sli 15 translocation to spindles, a readout of the FEAR network release of Cdc 14
(14, 22). Therefore, we examined whether overexpression of FOB] can also impair the
phosphorylation of Spol2 in anaphase. Overexpression of FOB] was induced during a
nocodazole arrest and maintained upon release from nocodazole. Spol2 was
phosphorylated to the same extent in both GAL-FOB] cells and wild type cells (Figure
7C). The timing of Spo 12 phosphorylation remains correlated with anaphase and was not
delayed by overexpression of FOB] (Figures 7C and 7D). This data indicates that Fob
does not affect Spo 12 phosphorylation, likely because Fob 1 functions downstream of
Spo 12 phosphorylation to affect the FEAR network function.
Examining the role of the FEAR network components in Spo 12 phosphorylation
has revealed that Cdc55, Fob 1, and Cdc5 are not required for Spol2 phosphorylation,
whereas Espl and Slkl9 are necessary to promote Spol2 phosphorylation.
Figure 7
B0 00
o 0 0 C (
C LO 1- M - 0
00 0
D 0 0 0 M (0C V) M I 0- M - ,'- '-
-pS118-Spo12
-Spol2-13Myc
-pS118-Spo12
-Spol2-13Myc
100
80
, 60
040
O
20
0
0 20 40 60 80 100 120 140 160
Time (min)
o Wild type Metaphase
s Wild type Anaphase
o foblA Metaphase
* foblA Anaphase
100
-pS118-Spo12
I-Spol 2-13Myc
-pS118-Spo12
-Spol2-13Myc
80
_ 60
0
S40
20
0 20 40 60 80 100 120
Time (min)
o GAL-FOB1 Metaphase
* GAL-FOB1 Anaphase
o Wild type Metaphase
* Wild type Anaphase
A
o
C
c
o C s m M - r- r-
D
C
C)5~~
Figure 7: Fob1 does not alter Spol2 phosphorylation
(A and B) SPO12-13MYC (A4568;0) andfoblA SPO12-13MYC (A10142;O) cells were
arrested in GI with a-factor (5[tg/mL) and released into fresh medium at 250 C. Spol2
protein was immunoprecipitated at each time point after release. Western blot analysis
on immunoprecipitate was done to detect phosphorylated Spol2 (A, top panels) and total
Spol2 protein (A, lower panels) as described in Experimental Procedures. The
percentage of cells in metaphase (open shapes) and anaphase (closed shapes) was
determined using tubulin staining at indicated times after release (B).
(C and D) SPO12-13MYC (A4568;D) and GAL-FOB] SPO12-13MYC (A18608;O) cells
were grown in YEPR medium and arrested in metaphase with nocodazole at 250C.
Expression of Fob 1 was induced 2 hr prior to release by addition of 2% galactose, and
cells were released into galactose-containing medium at 250 C. Spol2 protein was
immunoprecipitated at each time point after release. Western blot analysis on
immunoprecipitate was done to detect phosphorylated Spol2 (C, top panels) and total
Spol2 protein (C, lower panels) as described in Experimental Procedures. The
percentage of cells in metaphase (open shapes) and anaphase (closed shapes) was
determined using tubulin staining at indicated times after release (D). As noted in
Experimental Procedures, spindles must recover from nocodazole treatment before intact
spindles can be visualized and scored.
Spol2 phosphorylation is dependent on Cdc28
Having found that Espl and Slkl9 were required for Spol2 phosphorylation, we
next wanted to identify the kinase responsible for this modification. As Spo 12 is
phosphorylated during anaphase in cdcl5, cdc5, and dbf2 mutants, we knew those
kinases could not be responsible for this phosphorylation. The cyclin dependent kinase in
yeast, Cdc28, has been shown to phosphorylate substrates with a proline in the +1
position (13). Both serine 118 and serine 125 in Spol2 have a proline in the +1 position
(22). Additionally, mitotic-CDKs have already been shown to contribute to the
phosphorylation of Cfil/Netl in the nucleolus during early anaphase (1). Therefore, it is
possible that mitotic CDKs may have other nucleolar targets as well. Since serine 118 of
Spo 12 fits the Cdc28 target motif, we wanted to determine if Spo 12 phosphorylation in
anaphase is impacted by the loss of Cdc28 activity. To accomplish this we utilized the
cdc28-asl allele, which can be specifically inhibited with the ATP analog 1-NM-PP1 (2).
cdcl4-3 cells with and without the cdc28-asl allele were grown at the restrictive
temperature of 37oC to inactivate the cdcl4-3 gene product and to arrest the cells in
anaphase. In this anaphase arrest, Spo 12 was phosphorylated in both strains (Figures 8A
and 8B). These cells were then treated with the Cdc28-as inhibitor, 1-NM-PP1, to
inactivate Cdc28 in the cdcl4-3 cdc28-asl strain. The addition of inhibitor to cells
without the cdc28-asl allele did not affect cdcl4-3 cells, as these cells stayed in anaphase
and Spol2 remained phosphorylated (Figures 8A and 8B). However, Spol2
phosphorylation was lost within thirty minutes of the addition of inhibitor to cdcl4-3
cdc28-asl cells (Figures 8A and 8B). These cells were also able to exit from mitosis
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Figure 8: Cdc28 activity is required for Spol2 phosphorylation
(A and B) cdcl4-3 SPO12-13MYC (A6812; U) and cdcl4-3 cdc28-asl SP012-13MYC
(A20464; 0) cells were arrested in anaphase by growth at 37°C for 2 hours. Samples
were taken at the indicated time after addition of 51 M Cdc28-asl inhibitor to cells at
37C . Spol2 protein was immunoprecipitated at each time point. Western blot analysis
on immunoprecipitate was done to detect phosphorylated Spol2 (A, top panels) and total
Spo 2 protein (A, lower panels) as described in Experimental Procedures. The
percentage of cells in anaphase was determined using tubulin staining at indicated times
after release (B).
(C and D) SP012-13MYC (A4568;0J) and clblA clb2-VI SP012-13MYC (A18688;O)
cells were arrested in GI with a-factor (5ptg/mL) at 250 C and released into fresh medium
at 37°C. Spo 2 protein was immunoprecipitated at each time point after release.
Western blot analysis on immunoprecipitate was done to detect phosphorylated Spol2
(C, top panels) and total Spo 12 protein (C, lower panels). The percentage of cells in
metaphase (open shapes) and anaphase (closed shapes) was determined using tubulin
staining at indicated times after release (D).
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owing to the inactivation of Cdc28. These data argue that Cdc28 contributes to Spol2
phosphorylation during anaphase.
To further confirm that mitotic-CDK activity induces Spo 12 phosphorylation, the
effect of losing Clb 1-CDK and Clb2-CDK activity on Spo 12 phosphorylation was
ascertained using cells that have a temperature-sensitive allele of CLB2, clb2- VI, and in
which CLB1 was deleted. As Clb 1 and Clb2-CDK activity is important for proper
anaphase spindle elongation, clblA clb2- VI cells have a delay in entering anaphase (17).
However, over two hours after release from G 1 into the restrictive temperature, these
clblA clb2- VI cells do enter anaphase, which peaks at 160 minutes. However, despite
being in anaphase, these clblA clb2-VI cells show no Spol2 phosphorylation (Figures 8C
and 8D). Therefore, loss of both of the main mitotic cyclins or inhibition of Cdc28
activity during anaphase results in the absence of Spo 12 phosphorylation, arguing that
Spol2 phosphorylation is Cdc28 dependent.
We examined whether other kinases that have been previously implicated in
mitotic exit also affect Spol2 phosphorylation. The IplI kinase has been shown to be
important for proper microtubule and kinetochore attachments (15). Ipl 1, along with
Slil5, is translocated in a FEAR network dependent manner to the spindle during
anaphase, which then promotes Slk19 targeting to the spindle midzone (11, 14).
Therefore, we wanted to determine if the Ipll kinase was necessary for Spo 12
phosphorylation. Ipll activity is not needed for Spol2 phosphorylation, as Spol2
phosphorylation levels are normal in ipll-321 cells (Figures 9A and 9B). Another
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Figure 9: Ipll and Hogl are not required for Spol2 phosphorylation
(A and B) SP012-13MYC (A4568;0) and ipll-321 SP012-13MYC (A19262;O) cells
were arrested in metaphase at 250 C using nocodazole and released into fresh medium at
370 C as described in Experimental Procedures. Spol2 protein was immunoprecipitated
at each time point after release. Western blot analysis on immunoprecipitate was done to
detect phosphorylated Spol2 (A, top panels) and total Spol2 protein (A, lower panels).
The percentage of cells in metaphase (open shapes) and anaphase (closed shapes) was
determined using tubulin staining at indicated times after release (B). As noted in
Experimental Procedures, spindles must recover from nocodazole treatment before intact
spindles can be visualized and scored.
(C and D) SP012-13MYC (A4568;I0) and hoglA SP012-13MYC (A18602;O) cells
were arrested in metaphase at 250 C using nocodazole and released into fresh medium at
370 C as described in Experimental Procedures. Spol2 protein was immunoprecipitated
at each time point after release. Western blot analysis on immunoprecipitate was done to
detect phosphorylated Spol2 (C, top panels) and total Spol2 protein (C, lower panels).
The percentage of cells in metaphase (open shapes) and anaphase (closed shapes) was
determined using tubulin staining at indicated times after release (D). As noted in
Experimental Procedures, spindles must recover from nocodazole treatment before intact
spindles can be visualized and scored.
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candidate Spo 12 kinase is Hog 1l. Hogl has been shown to play a role in mitotic exit
since it can bring about exit from mitosis in MEN mutants at high osmolarity (18).
However, Spol2 is still phosphorylated in hoglA cells indicating that Hogl is not the
kinase responsible for phosphorylating Spol2 (Figures 9C and 9D). Neither the Ipll nor
Hogl kinases affect CDK-dependent Spo 12 phosphorylation.
Spol2 dephosphorylation in anaphase requires Cdcl4
In wild type cells, Spo 12 phosphorylation is lost as cells exit from mitosis (Figure
2C). Having established that Cdc28 is required for Spol2 phosphorylation, and since
mitotic-CDKs are inactivated during exit from mitosis, we wanted to examine the
mechanism behind Spol2 dephosphorylation at the end of the cell cycle. The APC/Ccdhl
targets Spol2 for proteasomal degradation (19). Cells in which CDH1 is deleted no
longer degrade Spol2 protein, and Spol2 protein levels remain constant throughout the
cell cycle. If Spo 12 phosphorylation is lost upon exit from mitosis due mainly to Spo 12
degradation, then Spol2 phosphorylation should be retained after mitotic exit in cdhlA
cells. To test this, CDH1 and cdhlA cells were arrested in anaphase using the cdcl5-2
allele at 37C, and as expected, under these conditions Spol2 was phosphorylated (Figure
10A, 0 min). These cells were then shifted to the permissive temperature of 250C. As
previously observed, at 250C cdc15-2 cells can exit from mitosis due to activation of the
MEN. Upon exit, Spol 2 becomes dephosphorylated in cdcl5-2 cells (Figures 10A and
10B). In cdcl5-2 cdhlA cells, Spol2 protein is not degraded; yet, Spol2 phosphorylation
is still lost as cells exit from mitosis. This argues that as wild type cells exit from mitosis,
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Figure 10: Spol2 dephosphorylation is dependent on Cdcl4 in anaphase
(A and B) cdcl5-2 SPO12-13MYC (A5170;E) and cdcl5-2 cdhl A SP012-13MYC
(A19074;0) cells were arrested in G1 with a-factor (5p g/mL) at 250 C and released into
fresh medium at 370 C for 2 hours to arrest in anaphase. Cells were then shifted down to
250 C. Samples were taken at the indicated time after shifting cells to 250 C. Spol2
protein was immunoprecipitated at each time point. Western blot analysis on
immunoprecipitate was done to detect phosphorylated Spol2 (A, top panels) and total
Spo 2 protein (A, lower panels) as described in Experimental Procedures. The
percentage of cells in anaphase was determined using tubulin staining at indicated times
after release (B).
(C and D) SP012-13MYC (A4568;O) and cdcl4-3 SP012-13MYC (A6812;O) cells
were arrested in Gi with a-factor (5[g/mL) at 25 0 C and released into fresh medium at
370 C. Spol2 protein was immunoprecipitated at each time point after release. Western
blot analysis on immunoprecipitate was done to detect phosphorylated Spol2 (C, top
panels) and total Spo 12 protein (C, lower panels). The percentage of cells in metaphase
(open shapes) and anaphase (closed shapes) was determined using tubulin staining at
indicated times after release (D).
(E and F) SPO12-13MYC (A4568;0), cdcl4-3 SP012-13MYC (A6812;O) and cdcl4-3
spo12-S118A-13MYC (A21788; 0) cells were arrested in metaphase at 250 C using
nocodazole and released into fresh medium at 370 C as described in Experimental
Procedures. Spo 2 protein was immunoprecipitated at each time point after release.
Western blot analysis on immunoprecipitate was done to detect phosphorylated Spol2 (E,
top panels) and total Spo 2 protein (E, lower panels). The percentage of cells in
metaphase (open shapes) and anaphase (closed shapes) was determined using tubulin
staining at indicated times after release (F). As noted in Experimental Procedures,
spindles must recover from nocodazole treatment before intact spindles can be visualized
and scored.
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the loss of Spo 12 phosphorylation is not due mainly to protein degradation. Instead,
Spol2 is likely to be actively dephosphorylated during late anaphase.
Since the phosphatase Cdcl4 is functional during exit from mitosis and Spo 2 is
phosphorylated in anaphase arrested cdcl4-3 cells (Figure 8A), we examined Spol2
phosphorylation in cdcl4-3 mutants throughout the cell cycle. Wild type and cdcl4-3
cells were synchronized in GI and then released into the cell cycle at 370C to inactivate
the cdcl4-3 gene product. Spol2 phosphorylation in wild type cells correlated with
anaphase as expected (Figures 10C and 10D). However, in cdcl4-3 cells, Spol2
phosphorylation occurred prematurely, seen first at 50 minutes after release and
remaining throughout the experiment (Figures 10C and 10D). Interestingly, 50 minutes
after release when Spol2 phosphorylation occurs, less than 10% of the cdcl4-3 cells are
in metaphase and none have entered anaphase. This argues that Cdcl4 can contribute to
the dephosphorylation of Spol2 at cell cycle stages other than just anaphase.
If Spo 12 was mislocalized in cdcl4-3 cells, this could result in a non-specific
phosphorylation event. However, Spol2 was localized normally in cdcl4-3 cells,
arguing that the premature phosphorylation seen in these cells is not due to Spol2
mislocalization (data not shown). Therefore, we wanted to reconfirm the specificity of
this Spo 2 phospho-antibody in these cdcl4-3 strains that show prematurely
phosphorylated Spol2. Wild type, cdc14-3, and cdcl4-3 SPO12-S118A cells were
arrested in metaphase using nocodazole at the permissive temperature and released at
37°C. Both wild type and cdcl4-3 cells show Spol2 phosphorylation as cells enter
anaphase (Figures 10E and 10 OF). Interestingly, some Spo 2 phosphorylation can even be
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seen 15 minutes after release in the cdcl4-3 cells when all cells are still in metaphase
(Figures 10E and 10F). cdcl4-3 cells expressing phospho-mutant SP012-S118A instead
of wild type SP012, do not show a Spol2 phosphorylation signal, which reconfirms the
specificity of this antibody against phosphorylated-S 118 (Figures 10E and 10F). The
premature Spol2 phosphorylation seen in cdcl4-3 cells is specific and not due to
mislocalization, arguing that Cdcl4 promotes Spo 12 dephosphorylation.
Cdcl4 is required to dephosphorylate Spol2 throughout the cell cycle
Despite the fact that less than 10% of the cdcl4-3 cells have entered metaphase,
Spol2 phosphorylation can already be seen, indicating that Cdcl4 may be required for
dephosphorylation of Spo 12 even before metaphase (Figures 10C and 10D). To test this
idea, wild type and cdcl4-3 cells were arrested in G1 at 250C, and no Spol2
phosphorylation was seen in these arrested cells (Time 0, Figure 11A). These cells were
then shifted to 37C and kept in the presence of alpha-factor. Inactivation of the cdcl4-3
gene product promoted cell cycle entry despite alpha-factor presence and induced Spol2
phosphorylation in cdcl4-3 cells but not wild type cells (Figure 11A). This implies that
Cdcl4 promotes Spol2 dephosphorylation throughout the cell cycle and not just in
mitosis. Inactivation of CDKs using the cdc28-as1 allele in such alpha-factor treated
cdcl4-3 cells resulted in the loss of the phospho-Spol2 signal (Figure 11B). These
results show that Cdcl4 is continuously required to maintain Spol2 in an
unphosphorylated state, which raises the interesting possibility that Cdcl4 may be active
while sequestered in the nucleolus.
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Figure 11: Spol2 dephosphorylation is dependent on Cdcl4 throughout
the cell cycle
(A) SP012-13MYC (A4568) and cdcl4-3 SPO12-13MYC (A6812) cells were arrested in
G1 with a-factor (5[tg/mL) at 250 C and shifted into medium with a-factor (5[tg/mL) at
370 C. Spol2 protein was immunoprecipitated at each time point after temperature shift.
Western blot analysis on immunoprecipitate was done to detect phosphorylated Spo 12
(top panels) and total Spol2 protein (lower panels).
(B) cdcl4-3 SP012-13MYC (A6812) and cdcl4-3 cdc28-as1 SP012-13MYC (A20464)
cells were arrested in G1 with a-factor (5pg/mL) at 250C and shifted into medium with
a-factor (5[tg/mL) at 370C. 60 minutes after temperature shift to 370C, cells were treated
with 5[tM Cdc28-asl inhibitor. Spol2 protein was immunoprecipitated at each time
point after temperature shift to 370C. Western blot analysis on immunoprecipitate was
done to detect phosphorylated Spol2 (top panels) and total Spol2 protein (lower panels).
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These experiments support the model that in a normal cell cycle, as cells progress
into late GI and Cdc28 becomes active, Spol2 is phosphorylated in a Cdc28 dependent
manner, which continues throughout the cell cycle until cells exit from mitosis when
CDKs are inactivated. However, Spo 12 phosphorylation is only seen in anaphase,
because Cdc 14 functions to counteract CDK-mediated phosphorylation of Spo 12
throughout most of the cell cycle. As the FEAR network signaling events occur in early
anaphase, Cdcl4 is no longer able to cause Spol2 dephosphorylation. This allows Spol2
to remain phosphorylated in a way that is necessary for function. We suspect that the
loss of Cdc 14 dephosphorylation of Spo 12 could be due to changes in Cdc 14 localization
or perhaps, and possibly more importantly, changes in the activity levels or substrate
specificity of Cdc 14.
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Discussion
Spol2 is phosphorylated in anaphase
The C-terminus of Spo 12 contains the conserved double serine-proline box
domain and is sufficient for Spol2 function (22). We show here that within the DSP box,
phosphorylation of two serines is essential for Spol2's FEAR function. Using a
phospho-specific antibody against Spol2 phosphorylated on serine 118, we show that
Spol2 phosphorylation peaks in anaphase, a time when Spo 12 functions in the FEAR
network. Spol2 phosphorylation is then lost as cells exit mitosis. Spol2
phosphorylation likely occurs in early anaphase, around the time when Cdcl4 is released
by the FEAR network. This idea is supported by the observation that components of the
MEN are not required for Spo 12 phosphorylation, but the FEAR network components
Espl and Slkl9 are. It has been previously shown that overexpression of SP012 rescues
the lethality of MEN mutants, but that GAL-SPO12 can promote Cdc 14 release only in
anaphase (22, 30). The mechanism of this cell cycle restriction was unknown. Given our
data, we know that the SP012 that is overexpressed in MEN mutants is likely to be in a
phosphorylated state and since this phosphorylation is required for function, Spol2 can
effectively promote Cdcl4 release in these cells. We propose that Spol2 is able to induce
Cdc 14 release only in anaphase because Spo 2 phosphorylation is restricted to anaphase.
How does the FEAR network contribute to Spol2 phosphorylation?
We have shown here that the FEAR network components Slkl9 and Espl are
necessary for Spol2 phosphorylation, which is also essential for Spol2 function in
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anaphase. These results indicate Slkl9 and Espl may function upstream of Spol2. Yet
previous work has shown that Slkl9 and Espl function in parallel to Spol2 in the FEAR
network, due to the additive nature of their effects on Cdcl4 release (30). However, the
previous experiments measured Cdcl4 release in slkl9A spol2A bnslA cells (30). Bnsl
is a protein with homology to Spol2 (7, 22). Loss of BNS1 on its own does not alter
Cdcl4 release, but it does subtly delay Cdcl4 release in spol2A cells (30). Therefore, it
is possible that the additive nature of the Cdc 14 release defects seen in slkl9A spol2A
bnslA cells compared to slkl9A cells and spol2A bnslA cells is due to the BNS1 deletion
(30). Indeed, examination of Cdcl4 release in slk19A, spol2A, and slk19A spol2A cells
in a BNS1 background, revealed that there is no longer a significantly additive Cdc 14
release phenotype in the slk19A spol2A double mutant (Rami Rahal, unpublished
observations). This indicates that Slkl9 and Esp function in the same branch of the
FEAR pathway as Spo12 (Figure 12). Previous observations showed that overexpression
of SP012 can rescue Cdcl4 release defects in slk19A cells, whereas overexpression of
ESP1 cannot rescue Cdcl4 release defects in either slkl9A cells or spo 2A cells (30).
Therefore, we believe Esp 1 functions upstream of Slkl 9 which in turn, functions
upstream of Spo 12 to induce the FEAR release of Cdc 14. This ordering of the pathway
is confirmed by the observation that both Slkl9 and Espl are required for Spol2
phosphorylation (11). Since the translocation of Slkl9 and Espl to the spindle midzone
in anaphase is dependent on Ipl1, but Spo 12 phosphorylation is not, we suspect that the
role for Espl and Slkl9 in promoting Spol2 phosphorylation occurs before their
relocalization to the midzone. Espl and Slkl9 could be functioning to promote Spol2
115
phosphorylation by enhancing the activity or access of Cdc28 to Spo 12 or by diminishing
the access of Cdc14 to dephosphorylate Spol 12.
Examination of cells lacking CDC55, one of the regulatory subunits of PP2A, did
not show any defects in Spol2 phosphorylation. Cdc55 has previously been shown to
affect CDK activity and was recently implicated in negatively regulating Cdc 14 release
and mitotic exit by being downregulated by Espl in anaphase, resulting in Cfil/Netl
hyper-phosphorylation by Cdc28 (1, 16). However, deletion of CDC55 in an espl-1
background did not rescue the Spol2 phosphorylation defect of espl-1 cells. These data
argue against the idea of Cdc55 being downstream of the role of Espl in Spol2
phosphorylation; instead it indicates that Cdc55 may be functioning upstream of Esp 1 in
the FEAR network. Another possibility is that Esp 1 regulation of Spo 12 does not involve
Cdc55, whereas regulation of Cfil/Netl phosphorylation does. However, this seems
unlikely because the same kinase, Cdc28, phosphorylates both Spol2 and Cfil/Netl,
which reside together in the nucleolus (1). Therefore, we believe Cdc55 functions
upstream of Esp 1 in the FEAR network.
Another protein shown to have inhibitory affects on the FEAR network release of
Cdc 14 is Fob 1, which is part of the regulator of nucleolar silencing and telophase exit
(RENT) complex, which also includes the proteins Sir2, Cfil/Netl, and Cdcl4 (10).
Fob 1 and Spo12 physically interact, and it has been proposed that Spol2 phosphorylation
destabilizes the Fobl-Spol2 interaction, which may in turn alter the Cdcl4-Cfil/Netl
interaction leading to Cdcl4 release (22). NeitherfoblA cells nor GAL-FOB] cells
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exhibited altered Spol2 phosphorylation. Consistent with genetics placing Fob
downstream of Spo 12, Fob does not affect Spol2 phosphorylation, confirming that its
role in the FEAR network release of Cdc 14 must be downstream of the induction of
Spo 12 phosphorylation.
Like Cfil/Netl, Spol2 is phosphorylated in a Cdc28 dependent manner
Upon inhibition of Cdc28 activity through the use of the cdc28-asl allele, Spol2
phosphorylation is lost. Additionally, removal of the majority of Clb-CDK activity does
not allow Spol2 phosphorylation to occur during anaphase. The Cdc28-dependence of
Spo 12 phosphorylation is not surprising, given that the phosphorylated residues on Spol2
have the characterized proline directed motif found in CDK substrates. Additionally,
Cdc28 has been previously implicated in the phosphorylation of the nucleolar protein,
Cfi l/Netl, in a manner that is important for the efficient FEAR network release of Cdc 14
(1). The deletion of the main mitotic cyclin CLB2 has previously been shown to mimic
the phenotype of a FEAR mutant, arguing that mitotic-CDKs are important for FEAR
network function (1). We believe that the function of mitotic-CDKs in promoting the
FEAR network release of Cdc 14 is derived not only from their contribution to Cfi 1/Net
phosphorylation, but also to the functionally significant CDK-dependent phosphorylation
of Spol2.
117
Cdcl4 promotes dephosphorylation of Spol2 throughout the cell cycle
The premature phosphorylation of Spo 12 seen in cdcl4-3 cells indicates that
Cdcl4 contributes to the dephosphorylation of Spol2 throughout the cell cycle. Since
Cdcl4 is bound to Cfil/Netl while in the nucleolus and Cfil/Netl is a competitive
inhibitor of Cdc 14, Cdcl4 has been assumed to be inactive while in the nucleolus (27,
29). However, recently it has been shown that Tof2, another nucleolar protein, interacts
with Cdcl4 and enhances its activity in vitro (6). In the nucleolus, Cdcl4 associates at
the rDNA mainly within the two non-transcribed spacer (NTS) regions (22). In a Fob 1-
dependent manner Cdc 14 and Tof2 more strongly associate with NTS 1, whereas
Cfil/Netl predominantly associates with NTS2 (9, 10, 22). As Tof2 is at the NTS1
region along with greater quantities of Cdc 14 than Cfi l/Netl, and Tof2 activates Cdc 14,
it is not surprising that Cdcl4 may have substrates within the nucleolus. Besides
inducing Spo 2 dephosphorylation, it is possible that Cdcl4 may also affect the
phosphorylation state of Cfil/Netl. Interestingly, cdcl4-1 cells grown for three hours at
the restrictive temperature show Cfil/Netl phosphorylation (1). Although we can
speculate that Cfil/Netl may be another potential substrate for Cdcl4 in the nucleolus,
we cannot rule out the possibility that the presence of this phosphorylation is merely the
result of the cells being arrested in anaphase. Having shown that Cdcl4 contributes to
Spo12 dephosphorylation, we favor the possibility that Cdcl4 directly dephosphorylates
Spo 12 for the following reasons: the phosphorylated serines of Spo 12 have the proline
directed Cdc 14 substrate motif, Cdc 14 and Spo 12 co-localize, and lastly the phosphatase
targeting Spol2 has activity in late anaphase as cells exit mitosis.
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In MEN mutants, Cdcl4 is resequestered in the nucleolus and yet Spol2
phosphorylation remains high. Why is Cdcl4 that is resequestered after the FEAR
network release in MEN mutants incapable of dephosphorylating Spo 12, whereas Cdc 14
that is sequestered in the nucleolus before the FEAR network activation capable of
dephosphorylating Spo 12? One idea is that high mitotic CDK activity may be able to out
compete the ability of Cdcl4 to maintain Spo12 in a dephosphorylated state. Another
possibility is that Cdcl4 may be unable to access Spol2 once resequestered after the
FEAR network release in a MEN mutant. Cdcl4 sequestered after the FEAR network
release may have a different nucleolar association profile than Cdc 14 sequestered before
the FEAR release, such that Cdcl4 is now unable to dephosphorylate Spo 12. However,
preliminary chromatin immunoprecipitation results argue against this idea (Danesh
Moazed lab, personal communication). If Cdcl4 localization is not altered, Cdcl4
resequestered after the FEAR network may remain in the phosphorylated state which is
not seen before the FEAR network is activated. Phosphorylation of Cdc 14 may alter its
affinity for substrates. Another, and not mutually exclusive, explanation for the
persistence of Spo 12 phosphorylation in MEN mutants is that Cdcl4 resequestered in a
MEN mutant is inactive. The MEN may be required not only to release Cdc 14, but also
to maintain Cdcl4 activity. This idea is supported by the observation that overexpression
of the Cdcl4 activator TOF2 rescues the temperature sensitivity of cdcl5-2 mutants,
indicating that enhancement of Cdc 14 activity can compensate for lack of signaling by
the MEN to induce mitotic exit (6).
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Although we observed that SPO12-SSAA could be found in both the nucleus and
nucleolus like wild type SP012, we cannot rule out that phosphorylation impacts Spol2
localization in a way that is functionally significant. Unfortunately, our Spo 12 antibody
did not work in immunofluorescence experiments designed to determine Spo 12
localization. If only one of these pools of Spo 12 is phosphorylated, perhaps this
phosphorylation directs a shuttling of Spo 12 from one compartment to another in a
mechanism that contributes to Cdcl4 release. Although it has not yet been determined if
CDKs are also localized in the nucleolus, CDKs promote phosphorylation of Cfil/Netl
which is only in the nucleolus (1). Therefore, CDKs are likely to reside either in the
nucleolus and act directly on these nucleolar substrates, or if CDKs are not in the
nucleolus, they contribute indirectly to these phosphorylation events.
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Figure 12: A model for mitotic exit
Given the data presented here, we propose this model for mitotic exit in budding yeast
(see Discussion). At the metaphase to anaphase transition, degradation of Pds 1 allows
Espl to be activated. Cdc55 functions either upstream of Esp or in a parallel branch of
the FEAR network. Espland Slkl9 promote CDK-mediated phosphorylation of
nucleolar proteins. This enhances the phosphorylation of Cfil/Netl, Spo 12, and possibly
Cdc 14 as well. Spol2 phosphorylation decreases the Fob l-Spol2 interaction and further
promotes the FEAR network release of Cdc 14. MEN activity is required to maintain
Cdc 14 release and phosphorylation. After the MEN release of Cdc 14, CDKs are
inactivated, and the APCCdhl targets Cdc5 for degradation, curtailing the MEN signaling
and allowing the resequestration of Cdcl4 in the nucleolus. Cdcl4 resequestered after
the MEN is likely to be in unphosphorylated state due to the lack of Cdc5 activity. Spo 12
phosphorylation is lost as cells exit from mitosis due to ability of Cdcl4 to induce Spo 12
dephosphorylation.
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A model of mitotic exit
Putting together all these considerations provides an updated model for mitotic
exit in budding yeast (Figure 12). At the metaphase to anaphase transition, degradation
of Pds allows Esp to be activated. Activation of Esp may alter the physical
interaction of Cdc55 and Espl, and in turn the Espl and Slkl9 interaction, such that
CDK-mediated phosphorylation of nucleolar proteins is promoted. This enhances the
phosphorylation of Cfil/Netl, which is contributed to by Cdc5 and Cdc28 (1, 20).
Cfil/Netl phosphorylation promotes Cdcl4 release from the nucleolus, yet this
phosphorylation alone is not sufficient for Cdc 14 release. This may be why Cdcl4
phosphorylation is also promoted by Cdc5, but possibly by other kinases as well (30).
Phosphorylation of Cdcl4 may interfere with its ability to dephosphorylate Spo 12,
allowing maintenance of the Cdc28 dependent Spol2 phosphorylation. Spo12
phosphorylation decreases the Fobl-Spol2 interaction and further promotes the FEAR
network release of Cdc 14 possibly by affecting the Cfil/Net 1-Cdc 14 interaction or the
association of Cdc 14 with NTS 1 in the rDNA. After the MEN release of Cdc 14, CDKs
are inactivated, and the APCCdh l targets Cdc5 for degradation, curtailing the MEN
signaling and allowing the resequestration of Cdcl4 in the nucleolus (31). Cdc 14
resequestered after the MEN is likely to be in unphosphorylated state due to the lack of
Cdc5 activity. Some subset of this unphosphorylated nucleolar Cdc 14, likely that which
is bound to Tof2, can actively dephosphorylate nucleolar substrates such as Spo 2.
Therefore, Spo 12 phosphorylation is lost as cells exit from mitosis due to ability of
Cdcl4 to induce Spol2 dephosphorylation.
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Using a newly developed Spo 12 phospho-specific antibody, we show here that the
early anaphase phosphorylation of Spo 12 is an important factor contributing to Cdc 14
regulation. Additionally, data showing that Cdcl4 promotes the dephosphorylation of
Spo 12 even before mitosis, lends further support to the interesting possibility that active
pools of Cdcl4 also reside in the nucleolus (6). The observation that Spol2 remains
phosphorylated in MEN mutants, despite Cdcl4 being resequestered in the nucleolus,
indicates that the MEN may play a unique role in activating Cdcl4 that is required for
full nucleolar release. This unique property of the MEN may explain why unlike the
FEAR network, the MEN is essential to mitotic exit in budding yeast.
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Materials and Methods
Yeast Strains and Plasmids:
All strains are isogenic with strain W303 (K699). Unless state otherwise, gene deletions
were constructed through one-step PCR as described previously (12). Spol2 phospho-
mutant strains were described previously (22).
Growth Conditions:
Growth conditions for individual experiments are described within the Figure legends.
Where growth conditions are unspecified, cells were grown in yeast extract peptone
(YEP) plus 2% glucose at 250 C. To obtain a G1 arrest, strains were arrested using a final
concentration of 5[pg/ml alpha-factor as described previously (25). Then 2.5tg/ml alpha-
factor was added to all cultures again 1.5 hours later to prevent escape from the arrest.
Strains were arrested in S phase by using 10 mg of hydroxyurea/ml as described
previously (25). If hydroxyurea arrest was longer than 2 hours, 5 mg/mL hydroxyurea
was re-added to all cultures to prevent escape from the arrest. In order to arrest cells in
metaphase, cells were first arrested in G 1 using alpha-factor, then released into media
containing nocodazole for 90 minutes. Nocodazole was resuspended in DMSO at
1.5mg/mL and used at a final concentration of 15 [tg per mL of culture media. If arrest
was longer than 90 minutes, nocodazole was re-added at a final concentration of 7.5 [tg
per mL of culture media. After release into fresh media with 1% DMSO, intact spindles
were unable to be visualized until approximately 30 minutes after release from
nocodazole. 1-NM-PP 1 inhibitor was used at indicated concentrations from 5mM DMSO
stock to inhibit Cdc28-asl (2). For the sporulation experiment, diploid cells were grown
to saturation in YPD (YEP + 2% glucose) for 24 hours, diluted into YPA (YEP + 2%
KAc) at OD 600 = 0.3 and grown overnight. Cells were then washed with water and
resuspended in SPO medium (0.3% KAc [pH = 7.0]) at OD600 = 1.9 at 250 C to induce
sporulation.
Whole cell immunofluorescence:
Indirect in situ immunofluorescence on whole cells was carried out as previously
described (29). Immunofluorescence samples were visualized using a Zeiss Axioplan 2
microscope. Unless otherwise indicated, 100 cells were scored per strain per time-point.
Rat anti-tubulin antibodies (Oxford Biotechnology) and anti-rat FITC antibodies (Jackson
Immunoresearch) were used at a 1:200 dilution.
Western Blot Analysis:
Western blot analysis was performed as previously described (28). Mouse anti-Vphl
antibodies (Molecular Probes) were used at 1:2000, mouse anti-Pgkl antibodies
(molecular Probes) were used at 1:25,000, mouse anti-Myc antibody (Covance) at a
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1:1000 dilution, and anti-mouse horseradish peroxidase-conjugated antibodies
(Amersham) were used at 1:2,000.
Immunoprecipitation:
Immunoprecipitation was done using 1:150 9E10 mouse anti-Myc antibody (Covance) in
the manner previously described (3).
Phospho-Antibody and detection:
Antibodies were custom-made by Abgent Technologies against phospho-S 118 Spo 12
using peptide QLQQRFA(pS)PTDRLVSC. The anti-phospho S 118 antibody was shown
to be phospho-specific on western blots of cell lysate (Figure 2). To detect Spol2 after
immunoprecipitation using these phospho-specific antibodies, blots were blocked for 8
hours at room temperature in 5% BSA in TBST, then incubated with the rabbit phospho-
antibody at 1:500 in 1.5% BSA in TBST overnight at 40 C. Blots were washed five times
with TBST and incubated with a goat anti-rabbit antibody conjugated to horseradish
peroxidase (HRP; Jackson Immunoresearch) at a 1:2000 dilution. A non-specific band
was seen in Western blots probed with the Spo 2 phospho-antibody (this band is noted
with an asterisk when present). This lower non-specific band was determined to be an
IgG band from the myc antibody used in the immunoprecipitation. In order to determine
accurate total Spo 2 protein levels, an anti-myc primary antibody directly conjugated to
horseradish peroxidase (HRP) (anti-myc-HRP, Invitrogen) was used to recognize Spol2
by Western blot. To do this, blots were blocked for 30 minutes in 3% milk in PBST, then
incubated with anti-myc-HRP in 1% milk/1% BSA in PBST at a concentration of 1:4000
for 2 hours at room temperature.
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Chapter IV
Discussion and Future Directions
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Summary
During mitotic growth, the series of events that culminate in the formation of two
daughter cells from one parental cell is called the cell cycle. The essential phosphatase
Cdcl4 acts late in the budding yeast cell cycle to drive exit from mitosis (25). In early
anaphase, the Cdc fourteen early anaphase release (FEAR) network drives the release of
Cdcl4 from the nucleolus which contributes to spindle stability and proper segregation of
specialized genomic regions such as ribosomal DNA (rDNA) and telomeres (3, 7, 20, 22,
24, 29). This thesis describes data showing that Cdcl4 is required for rDNA segregation
to resolve linkages established by rRNA transcription-dependent processes. Future
experiments will be aimed at elucidating what aspects of rDNA transcription are targeted
for Cdc 14-dependent resolution and identification of other potential proteins involved in
this process. This thesis has also shown the importance of the phosphorylation of Spo 12
for proper FEAR network release of Cdcl4. Now that both the kinase Cdc28 and the
phosphatase Cdcl4 are implicated in regulating Spol2 phosphorylation, further work can
determine whether these proteins act directly or indirectly on Spo 12. This work has
allowed us to propose an updated model of mitotic exit in budding yeast. Future
experiments can be aimed at confirming the specific aspects of Cdc 14 regulation that
have been postulated herein.
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Key Conclusions and Future Directions
The role of Cdcl4 in resolving transcription-dependent linkages at the rDNA
Previous work in budding yeast has indicated that the rDNA array requires
mechanisms beyond cohesin removal for proper segregation (3, 22, 24, 29). The delay in
segregation of the nucleolus in cdcl4 mutants as judged by immunofluorescence staining
of nucleolar proteins, implicated the phosphatase Cdcl4 in regulating rDNA segregation
(23). The FEAR network release of Cdcl4, not the MEN release, promoted rDNA
segregation, as nucleolar segregation defects were seen in cdcl4-3 mutants but not
cdcl5-2 mutants. How does Cdcl4 impact rDNA segregation? The FEAR network
release of Cdc 14 is required for localization of a subunit of the condensin complex, Ycs4,
to the nucleolus (3). Additionally, Cdcl4 is necessary for the sumoylation of Ycs4,
which may be the means by which Ycs4 is targeted to the nucleolus (3). Condensin
mutants were also observed to have defects in segregating rDNA (3, 22, 29). Therefore,
the model put forth was that Cdc 14 released by the FEAR network somehow triggers the
sumoylation of Ycs4, which helps to target the condensin complex to the rDNA where it
is needed to segregate the rDNA. However, the question of why rDNA requires extra
mechanisms for proper segregation remained unanswered.
The rDNA has many unique properties that may be contributing to its special
requirements for segregation. rDNA is highly repetitive, existing as a tandem array of
9kB repeats on chromosome XII in budding yeast (14). The array length can contract and
expand due to recombination between repeats, which is affected by the actions of a
number of proteins including Sir2 and Fobl (11, 13). The rDNA is the site of the
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majority of transcription in the cell, driven mainly by the action of RNA Polymerase I
(Pol I) (30). My work investigated whether any of these properties were responsible for
the assistance of Cdcl4 required to segregate this region (see Chapter II, 23). The repeat
length of the rDNA array did not affect its segregation, as cells with 25 copies of the
repeat, the wild type 150 copies of the repeat, or 400 copies of the repeat all required
Cdcl4 for proper segregation. Genes involved in the process of recombination that
controls expansion and contraction of the rDNA array also did not affect rDNA
segregation, indicating recombination does not necessitate the activity of Cdc 14 for
rDNA segregation.
However, the protein that sequesters Cdcl4 in the nucleolus, Cfil/Netl, did affect
rDNA segregation. cdcl4-3 cells lacking CFI1/NET1 did not have the same rDNA
segregation defect as cdcl4-3 cells, indicating that CFII normally functions to negatively
impact segregation of the rDNA. Cells with a depletion allele of Cdcl4 that lacked
CFI/NET1 also segregated their rDNA with near wild type kinetics. This suggests that
it is not Cfil/Netl's role in regulating Cdcl4 activity and localization that normally
hinders rDNA segregation.
Cfil/Netl is required for efficient transcription of the rDNA (19). Therefore we
investigated the role of transcription in rDNA segregation. The drug thiolution, which
inhibits all three RNA polymerases in yeast, rescues the rDNA segregation defect of
cdcl4-3 and condensin mutant cells indicating that transcription normally opposes
segregation (10). We also determined the effects of directly blocking just RNA
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Polymerase I transcription, which is the main polymerase responsible for transcribing the
rDNA, by utilizing a conditional allele of the largest Pol I subunit, Rpa135 (4). When
Rpa135 is degraded, Pol I transcription is blocked, and rDNA segregation can occur in
cdc14-3 cells. This data indicates that Cdcl4 is required for rDNA segregation to resolve
linkages established by transcription. Further experiments need to test what aspects of
transcription are impacted by Cdcl4 and condensin recruitment to the rDNA.
Unlike budding yeast, higher organisms have evolved mechanisms to shut down
transcription during mitosis (15). Experiments allowing the artificial reappearance of
RNA Polymerase II machinery on chromosomes during mitosis lead to chromosomal
segregation defects in human cells (9). This indicates that transcription impedes normal
chromosome segregation, which may be why rDNA in budding yeast requires a special
targeting of condensin during mitosis. Recent work shows that Polymerase I
transcription in budding yeast interferes with the ability of condensin to associate at the
rDNA (12). It remains to be understood how Cdcl4 counteracts this, and facilitates
condensin to promote rDNA despite transcription. Is simply the recruitment of condensin
to rDNA sufficient for segregation, or does Cdcl4 act in additional ways to mediate the
condensation process? Finding ways to artificially target condensin subunits to the
nucleolus independently of Cdcl4 could answer this question. If localization of
condensin to rDNA in the absence of Cdcl4 release allowed for proper rDNA
segregation, this indicates the only role of Cdc 14 in rDNA segregation is to target the
condensin complex to rDNA.
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However, Cdcl4 has been shown to physically interact with Rrn9, a component of
the upstream activating factor complex necessary for recruitment of RNA Polymerase I to
rDNA during transcription (31). This may indicate that Cdcl4 plays a more complicated
role in this process and possibly even impacts rDNA transcription directly. As
phosphorylation status of many proteins involved in Pol I transcription affect
transcriptional activity, it is possible that Cdcl4 dephosphorylates some of these proteins
to alter rDNA transcription and allow for segregation (5). Measuring the accumulation of
rRNA in cdcl4-3 cells, as has been done for cfil/netl mutant cells, can determine
whether Cdcl4 affects rDNA transcription (19). If Cdcl4 normally dampens
transcription enough to allow for proper rDNA segregation, cdcl4-3 cells should have
higher levels of transcription.
Transcription at the rDNA produces long rRNA primary transcripts that must go
through extensive processing in the nucleolus before mature rRNAs are formed.
Processing of rRNA requires many proteins that assemble onto rRNA cotranscriptionally
and the steps of this process have been well elucidated (18). Given our data, we cannot
currently determine whether it is the process of transcribing the primary rRNA transcripts
that is impeding segregation and/or the extensive processing of these transcripts.
Targeted degradation of essential components involved in rRNA processing by the use of
conditional alleles in anaphase and then examining rDNA segregation may indicate
whether rRNA processing normally interferes with rDNA segregation. If rRNA
processing is determined not to impact segregation, then determining what aspects of
transcription of the rDNA do impact segregation should be investigated. Understanding
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how transcription impedes rDNA segregation may better define the interplay of complex
cellular processes such as chromosome segregation and transcription. Additionally,
recent research has suggested that exogenous topoisomerase, which resolves catentation,
can compensate for the loss of condensin in rDNA segregation in a manner independent
of altering rDNA transcription (3). Therefore, additional work needs to be done to define
all the essential targets needed to achieve proper rDNA segregation to determine if
multiple mechanisms exist to enhance rDNA segregation.
Regulation of Spol2 phosphorylation by the FEAR network in anaphase
Previous work from our lab showed that the FEAR network component Spo 12 is
phosphorylated on two conserved C-terminal serines, serine 118 (S 118) and serine 125
(S125) (21). Spol2 phosphorylation levels were measured in exponentially growing
cells, S-phase arrested cells, and metaphase arrested cells (21). Cells growing
exponentially had the highest Spol2 phosphorylation levels, indicating that Spo12
phosphorylation peaks in cell cycle stage(s) other than S phase or metaphase. Because
Spo 2 protein is degraded in G 1, Spol2 phosphorylation levels were predicted to be
maximal in anaphase. Additionally, Spo 12 was shown to physically interact with Fob 1, a
negative regulator of the FEAR network (21). Since the association of Fob and Spol2
was dampened when Spol2 was phosphorylated, Spol2 phosphorylation was proposed to
alleviate the inhibitory function of Fob 1, thereby positively contributing to Cdc 14 release
in early anaphase.
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My research continued the investigation into the significance and regulation of
Spol 2 phosphorylation (see Chapter III). I found that Spol2 phospho-mutants have
similar characteristics to spol2A cells including a delay in exiting mitosis, the inability to
rescue growth in ItelA strains, and defects forming tetranucleates during meiosis. Since
Spol2 phospho-mutant strains lack Spo 12 function, we believe that phosphorylation of
Spo 2 is required for its function to induce the FEAR network release of Cdcl4 from the
nucleolus.
The development of an antibody specific to Spo 12 phosphorylated on S118
allowed us to more directly measure Spo 2 phosphorylation throughout the cell cycle.
By using this antibody, we determined that Spo 2 phosphorylation occurs when cells are
in anaphase. Additionally, Spol2 phosphorylation is lost as cells exit from mitosis.
Knowing Spo 2 phosphorylation is restricted to anaphase, as is the activity of both the
MEN and the FEAR network, we then determined whether mutants of these signaling
pathway components impact Spo 12 phosphorylation. The MEN was shown not to affect
Spol2 phosphorylation. However, in MEN mutants, cells cannot exit mitosis due to
impaired CDK inactivation, and Spol2 remains phosphorylated in these cells.
Spo12 phosphorylation requires both Slkl9 and Espl, which function in the same
branch of the FEAR network. Previous work had indicated that Spo 12 was likely to be
functioning in a parallel pathway to Slkl9 and Espl because slkl9A spol2A bnslA cells
had a stronger Cdcl4 release defect than slkl9A cells (27). However, given our data
showing the dependence of Spo 12 phosphorylation on Espl and Slkl9 and that this
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phosphorylation was essential, it seemed more likely that Spol2 was functioning
downstream in the same branch of the FEAR pathway. Therefore, Cdcl4 was reanalyzed
in these mutant strains in a BNSI background, and there is no longer a significantly
additive Cdcl4 release phenotype in the slkl9A spol2A double mutant (Rami Rahal,
unpublished observations). This indicates that Slkl9 and Esp may indeed be
functioning in the same branch of the FEAR pathway as Spo 12.
Cdc55, a regulatory subunit of the PP2A phosphatase, was also shown to
negatively regulate Cdc 14 release until anaphase onset when it is downregulated by Esp 1,
resulting in Cfil/Netl hyper-phosphorylation by Cdc28 (16). Loss of CDC55 did not
alter Spo 12 phosphorylation. This was surprising because if the main role of Espl in the
FEAR pathway is to inactivate Cdc55, then loss of CDC55 would have been expected to
have some affect on Spo 12 phosphorylation. Furthermore, deletion of CDC55 in an
espl-1 background did not rescue the Spo12 phosphorylation defect of espl-1 cells.
Overall, this data argues that the FEAR pathway should be redrawn such that Cdc55 may
be functioning upstream of or in parallel to Esp in FEAR network function (Figure 1).
There is evidence in meiosis that Cdc55 is required for Esp 1 activation, so we favor the
model placing Cdc55 upstream of Espl (Adele Marston, personal communication).
Fob 1, another negative regulator of the FEAR network, does not impact Spo 12
phosphorylation. Neither overexpression nor deletion of FOB1 affected Spol2
phosphorylation; therefore, we conclude that Fob l's role in affecting Cdcl4 release must
be downstream of the induction of Spo 12 phosphorylation, which is consistent with
previous genetic epistasis.
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Figure 1: Refining the current models of the FEAR network
(A) As described in Chapter I, Cdc55 is thought to function downstream of Espl in the
FEAR network. Downregulation of Cdc55 by Espl upon anaphase entry promotes CDK
phosphorylation of Cfil/Netl, which drives the FEAR network release of Cdcl4. Cdc5
functions in a separate branch of the FEAR network and promotes Cdc 14
phosphorylation. In a third branch of the FEAR network, Spo 12 inhibits Fob 1 to promote
Cdc 14 release.
(B) Given the data presented in Chapter III, we propose this updated model for the FEAR
network. Cdc55 functions either upstream of Espl or in a parallel branch of the FEAR
network. Esp land Slkl9 promote CDK-mediated phosphorylation of nucleolar proteins
such as Spol2 and Cfil. Our data puts Spol2 downstream of Espl and Slkl9 in the same
branch of the FEAR network. Upon phosphorylation, Spo 12 removes the inhibitory
function of Fob 1, such that the FEAR network release of Cdc 14 is promoted.
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We show that phosphorylation of Spo 12 is dependent on the activity of the cyclin
dependent kinase Cdc28. This is not surprising as S118 of Spol2 has the proline
directed motif of CDK targets (21). Cdc28's promotion of Spo 12 phosphorylation seems
to depend on the overall levels of kinase activity during the cell cycle, as opposed to
specific cyclins, since we see a requirement for Cdc28 from late G 1 through mitosis.
Cdc 14 dephosphorylates many CDK substrates utilizing the same proline directed motif
as Cdc28 (25). Spol2 has been shown to be another example of a protein that is targeted
by both CDK and Cdc 14. Cdcl4 promotes dephosphorylation of Spo 12 throughout the
cell cycle until it is released by the FEAR network in early anaphase. Spo 2 stays
phosphorylated until the MEN is activated and it is dephosphorylated during exit from
mitosis.
These observations have allowed us to establish an updated model for exit from
mitosis in budding yeast (Figure 1). At the metaphase to anaphase transition, degradation
of Pdsl allows Espl to be activated. Espl and Slkl9 function together to promote CDK-
mediated phosphorylation of nucleolar proteins. This enhances the phosphorylation of
Cfil/Netl, which in turn promotes Cdcl4 release from the nucleolus (1, 16).
Additionally Cdcl4 phosphorylation occurs, and this may interfere with its ability to
dephosphorylate Spol2, thereby allowing maintenance of the Cdc28 dependent Spol2
phosphorylation. Spol2 phosphorylation decreases the Fobl-Spol2 interaction and
further promotes the FEAR network release of Cdcl4 (21). After MEN release of Cdcl4,
CDKs are inactivated, and the APCCdhl targets Cdc5 for degradation, curtailing the MEN
signaling and allowing the resequestration of Cdcl4 in the nucleolus (28). This
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resequestered Cdc 14 can dephosphorylate Spo 12, leading to loss of Spo 12
phosphorylation as cells exit from mitosis until they reach anaphase of the next cell cycle.
Having defined Spo 12 phosphorylation as a read-out of the activation of the FEAR
network, measurement of Spo 12 phosphorylation will be a useful tool for further studies
characterizing the Cdcl4 signaling pathways in mitosis and meiosis.
We propose that Cdc28 and Cdcl4 are impacting the status of Spo12
phosphorylation throughout most of the cell cycle. It remains to be tested whether Slkl9
and Esp 1, which are required for Spo 12 phosphorylation in anaphase, can impact Spo 12
phosphorylation earlier in the cell cycle as well. This would be surprising as activation of
components of the FEAR network is presumably limited to early anaphase in order to
restrict their promotion of Cdc 14 release to that stage of the cell cycle.
The data presented here opens up a number of interesting questions that can be
explored in future experiments. Although we speculate that Cdcl4 and Cdc28 act
directly on Spo 12 to affect its phosphorylation, this idea should be examined using in
vitro kinase and phosphatase assays. If indeed their action on Spo 12 is direct and can be
reconstituted in vitro, adding other proteins such as those shown here to positively or
negatively affect Spo 12 phosphorylation, to these in vitro reactions may reveal whether
those proteins also can directly enhance or dampen enzyme activity or if their effects
require the in vivo cellular context.
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Fobl is required for the association of the Cdcl4, Cfil/Netl, Sir2, and Tof2 to the
NTS1 region in the rDNA (8). Having shown that Fob functions in inhibiting Cdcl4
release downstream of the induction of Spo 12 phosphorylation, we suspect that Fob 1
may be impacting the interactions between Cfil/Netl and Cdcl4 or alter the ability of
these proteins to associate with the rDNA. Therefore it may be interesting to examine by
immunoprecipitation (IP), the extent of interaction between Cdcl4 and Cfil/Netl in wild
type,foblA, spol2A, SPO12-SSAA, and GAL-FOB1 cells before the FEAR network is
activated and in MEN mutant cells that will arrest after the FEAR network has been
activated. Additionally, chromatin-IP (ChIP) can determine the relative association of
Cdcl4, Cfil/Netl and Fob with the rDNA in these cells. We suspect that Cdcl4 that is
resequestered in MEN mutants will have a weaker association with Cfil/Netl or show
altered ChIP profiles as compared to cells arrested before the FEAR network has been
activated. Additionally, this altered interaction seen after Cdc 14 resequestration, may be
dependent on Fob 1 expression and Spo 12 phosphorylation. These proposed experiments
are all designed to better understand Spol2 phosphorylation, and will in turn, help
elucidate the series of events involved in the FEAR network release of Cdc 14.
Does Spol2 phosphorylation indicate that Cdc14 is active in the nucleolus?
Recent research suggests that the nucleolar protein Tof2 directly binds Cdcl4,
enhances the phosphatase activity of Cdc 14 in vitro, and supports Cdcl4's functions in
anaphase (6). These results indicate that there may be a pool of active Cdc 14 residing in
the nucleolus, separate from the pool of Cdc 14 bound to its inhibitor Cfil/Netl.
Therefore, examining the Spol2 phosphorylation levels across the cell cycle in a tof2A
143
mutant may reveal a premature phospho-signal due to the decreased Cdcl4 activity in the
nucleolus, which diminishes Cdc14-dependent Spol2 de-phosphorylation. It would also
be interesting to identify other nucleolar substrates of Cdc 14. Preliminary evidence
indicates that Cfil/Netl may be another substrate for Cdcl4. As with Spol2, Cfil/Netl
phosphorylation is seen in cdcl4 mutants arrested in an anaphase and CDKs are
responsible for Cfil/Netl phosphorylation (1). To confirm that Cfil/Netl is indeed a
target of Cdcl4, Cfil/Netl phosphorylation levels can be measured in cdcl4 mutants at
other stages of the cell cycle, as was done for Spo 12, and we would expect to see
prematurely phosphorylated Cfil/Netl in cdcl4 mutants.
Additionally, the observation that Spol2 remains phosphorylated in MEN mutants
should be further explored. Why is Cdcl4 that is resequestered after the FEAR network
release in MEN mutants incapable of dephosphorylating Spo 12, whereas Cdcl4 that is
sequestered in the nucleolus before the FEAR network activation capable of
dephosphorylating Spo 12? We proposed a number of possible explanations for this
observation that need to be tested. One idea is that high mitotic CDK activity may be
able to out compete the ability of Cdc 14 to maintain Spo 12 in a dephosphorylated state.
This hypothesis could be tested by decreasing cyclin activity in a MEN mutant strain, for
example a clblA clb2-IVcdcl5-2 strain, and measuring Spol2 phosphorylation levels. If
CDK levels can normally outcompete Cdcl4 dephosphorylation, then the loss of the
majority of mitotic CDK activity may allow Spo12 to be dephosphorylated in MEN
mutant strains. Another possibility is that Cdc 4 may be unable to access Spol2 upon
resequestration after the FEAR network release. Cdcl4 sequestered after the FEAR
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network release may have a different nucleolar association profile than Cdc 14
sequestered before the FEAR network release, such that Cdc 14 is now unable to
dephosphorylate Spo 12. Preliminary chromatin immunoprecipitation results argue
against this idea (Danesh Moazed lab, personal communication). If Cdc 14 localization is
not altered, Cdcl4 resequestered after the FEAR network may remain in the
phosphorylated state that is not seen before the FEAR network release, and normally the
MEN will lead to dephosphorylation of Cdc 14 during mitotic exit. The phosphorylation
of Cdcl4 may alter its affinity for substrates. Using Cdcl4 purified from cells in which
CDC14 contains its potential phospho-sites mutated to alanines, for in vitro kinase assays
with Spo 12 and other mitotic targets of Cdc 14, may reveal that Cdc 14 phosphorylation
regulates substrate specificity in different cell cycle stages.
Another, and not mutually exclusive, explanation for the persistence of Spo 12
phosphorylation in MEN mutants is that Cdcl4 resequestered after the FEAR network
release is inactive. The MEN may be required not only to release Cdcl4, but also to
maintain Cdc 14 activity. Examining the kinetics of cell cycle progression and mitotic
exit in cfilA and cfilA cdc15-2 cells can test this idea. In cfilA cells, Cdcl4 cannot be
resequestered in the nucleolus and so remains released in these cells (26). This
constitutively released Cdcl4 dampens CDK activity levels and makes these cells have
extreme cell cycle delays. If the MEN was required to activate Cdc 14, then Cdc 14 in
cfilA cdc15-2 cells should be less active and therefore have less cell cycle delays then
cfilA cells. If it is determined that the MEN is indeed needed for Cdc 14 activation, this
may be why it is the MEN but not the FEAR network that is essential in budding yeast.
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Unfortunately, our Spo 12 antibody did not work in immunofluorescence
experiments designed to determine Spol2 localization. Developing such a tool however,
could prove very useful to enhancing our understanding of Spo 12 phosphorylation.
Although we observed that SPO12-SSAA could be found in both the nucleus and
nucleolus like wild type SP012, we cannot rule out that phosphorylation impacts Spol2
localization in a way that is functionally significant. Let us assume that it is possible that
only one of these pools of Spo 12 is phosphorylated, perhaps this phosphorylation directs
a shuttling of Spo 12 from one compartment to another. Although CDKs have been
shown to promote phosphorylation of Cfil/Netl which is only in the nucleolus, it has not
yet been determined if CDKs are also localized in the nucleolus (1). If nucleolar CDKs
were to be observed, this would be indirect evidence that the kinase is in the right place to
act directly on nucleolar substrates. If however, CDKs were not observed to ever be
nucleolar this may indicate that their actions on nucleolar proteins are indirect, or in the
case of Spo 12 maybe only the nuclear pool is phosphorylated. If it is the nucleolar pool
of Spol2 that is phosphorylated, then measurements of Spo 12 phosphorylation in cfilA
cells, in which Cdc 14 is not nucleolar, may reveal a constitutively phosphorylated Spo 12.
However, if it is nuclear Spo 12 that is phosphorylated then Cdc 14 is likely to still be able
to dephosphorylate Spol2 in cf1A cells. These experiments may provide evidence
indicating that one of the two pools of Spo 12 is preferentially phosphorylated, but until
we can detect the localization of phospho-Spol2 we cannot be certain if it is a localized
subset of Spo 12 that is phosphorylated or if all Spo 12 is phosphorylated. All of the
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aforementioned experiments can help to enhance our current understanding about the
regulation of Spol2 phosphorylation and other events during exit from mitosis.
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Concluding remarks
Since the discovery of the Cdc 14 phosphatase as the key trigger of CDK
inactivation during anaphase, much work has been done to characterize the signaling
networks that regulate Cdc 14. Although many proteins of these signaling pathways have
been identified, the models detailing the key events of anaphase continue to be refined as
new data emerges. Despite this, the functions of Cdcl4 in budding yeast are much more
defined than in other organisms. Recent work suggests that in a human ancestral species,
the CDC14B gene underwent rapid adaptive protein evolution such that tissue specific
forms of Cdcl4 evolved (17). Therefore, as Cdc 14 homologs are studied in more detail
in higher eukaryotes, it will be interesting to ascertain the extent of conservation of
Cdcl4 functions among eukaryotes.
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Appendix I
Analysis of mutants generated in a screen aimed at identifying
positive regulators of mitotic exit
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Introduction
It is important to faithfully partition the genome to daughter cells during cell
division in order to avoid having abnormal chromosome numbers that can cause disease
states. To prevent aneuploidy, late cell cycle events are carefully regulated to ensure that
cytokinesis occurs only after chromosomes are properly segregated into the mother and
daughter cells. An essential mitotic regulator in Saccharomyces cerevisiae is the
phosphatase Cdc 14, which antagonizes cyclin dependent kinase (CDK) activity to allow
for exit from mitosis (7). Prior to anaphase, Cdc 14 resides in the nucleolus, where it is
bound to its inhibitor Cfil/Netl (8). During late anaphase, Cdcl4 is released from the
nucleolus by the mitotic exit network (MEN) (3). The essential MEN signaling pathway
most closely resembles a Ras-like GTPase signaling cascade. Components of the MEN
include the scaffold protein Nudl, the GTPase Tem , the two component GTPase
activating protein (GAP) Bub2-Bfal, the putative guanine nucleotide exchange factor
(GEF) Ltel, the protein kinases Cdc 15, Dbf2, and Cdc5, and the Dbf2 activating protein
Mob1 (3).
In order to identify potential novel components of the MEN, a former graduate
student in the lab conducted a genetic screen to identify possible new components
involved in mitotic exit (2). This screen was based on established method, in which
lethality caused by partial loss of function of effectors in an essential signaling pathway
can be rescued by the overexpression of a gene of interest, which is another component of
the pathway (1). Our screen was conducted using three different essential kinases
involved in the MEN: CDC5, CDC15, and DBF2. This screen generated many new
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alleles of known MEN components as well as mutations in genes that need to be
identified. One interesting allele characterized to date is the cdcl4-doe2 allele, which
may enhance our understanding of the regulation of Cdc 14 by the MEN.
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Results
Results of the previously conducted screen
To conduct the screen to identify new regulators of mitotic exit, three different
strains were made, each with one of the MEN kinase genes, CDC5, CDC15, or DBF2,
under the control of the inducible GAL1-O promoter integrated at a non-endogenous
locus in the genome. Depending on the growth conditions, the MEN kinase of interest
can either be overexpressed in media with galactose, or repressed in media with dextrose.
Each of the three strains, GAL-CDC5, GAL-CDC15, and GAL-DBF2, were
exposed to the mutagen ethyl methanesulfonate (EMS), which generally induces point
mutations. The mutagenized cells were then grown on galactose, to overexpress one of
the above mentioned MEN kinases. The resulting colonies were replica plated to glucose
media at various temperatures. The dye Phloxin B, which is taken up by dead cells, was
used in the media to easily screen for inviable colonies. 77 colonies were selected that
grew only in the presence of galactose (Table 1). 29 of these mutants were identified to
be false positives, as comparison of growth in media with both galactose and glucose
looked the same as on galactose alone. The other mutants from the screen were mated to
temperature sensitive alleles of known MEN components in order to check for non-
complementation of the diploid at restrictive temperature. In this way, 29 mutants were
identified as alleles of CDC5, TEM1, or DBF2. The remaining 19 mutants were termed
dependent on overexpression (doe) mutants. Four mutants with the strongest growth
difference between galactose and glucose media were selected for further analysis and
termed doel-4 respectively (Figure 1).
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Table 1: Results of screen
Total Number
Colonies of False DBF2 CDC5 TEMI Unknown
Screened Mutants Positives alleles alleles alleles Mutants
GAL-DBF2 220960 12 4 4 0 0 4
GAL-CDC5 268000 41 12 2 19 1 6
GAL-CDC15 237000 24 13 0 0 3 8
Total 725960 77 29 6 19 4 18
Unknown Mutants: Strong Phenotype
(doel-4)
GAL-DBF2 (4) 1
GAL-CDC5 (6) 1
GAL-CDC15 (8) 2
Total (18) 4
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GAL-DBF2 doel at 300
- r GAL-CDC5 doe2 at 360
-- GAL-CDCI 5 doe3 at 36'
- GAL-CDC15 doe4 at 360
YPD Raf/Gal
Figure 1: Dependent on over-expression mutants isolated from the screen
GAL-DBF2 doel (K15), GAL-CDC5 doe2 (K68), GAL-CDC15 doe3 (K154),
and GAL-CDC15 doe4 (K160) cells were grown at the indicated temperatures
for three days on solid media without galactose (left panels) or in the presence
of galactose (right panels).
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Characterization of the screen mutants doel, doe2, doe3, and doe4
When grown on media without galactose, doel-4 mutants were temperature-
sensitive inviable at 370C and the temperature-sensitivity phenotype was recessive (data
not shown and Figure 1). The doe mutants were further tested for growth on media with
and without galactose at temperatures between 25°C and 37°C (data not shown). Doel
exhibited the strongest temperature-sensitive phenotype with a restrictive temperature of
30'C when grown on glucose. doe2, doe3, and doe4 all had a restrictive temperature
between 34°C and 37°C degrees when grown on glucose. When grown in the presence of
galactose, the doe temperature sensitivity was rescued, because doe2, doe3, and doe4
cells can now grow at 37C and doel at 300 C. This observation confirms that these
mutants require the overexpression of a MEN kinase for viability at high temperatures.
Since these mutants can be followed by their temperature sensitivity when the
MEN kinase is not being overexpressed, doel-4 strains isolated from the screen were
backcrossed to wild-type cells. Strains were selected that did not have an overexpressed
MEN component and were temperature sensitive. These mutant strains were then used in
synchronous cell cycle experiments at the restrictive temperature in order to see where
these doe mutants arrest in the cell cycle. MEN mutants can replicate their DNA, but
normally arrest in anaphase, as they are unable to exit from mitosis. To determine
whether the doe mutants display any cell cycle progression defects, G1-synchronized
cells were grown in glucose at the permissive temperature; arrested cells were then
released to enter the cell cycle at the restrictive temperature of 37C. Samples were
collected every twenty minutes for four hours at the restrictive temperature, and
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processed for both fluorescence activated cell sorting (FACS) analysis to determine DNA
content and for tubulin indirect immunofluorescence to monitor spindle progression and
morphology (Figure 2-5).
As seen in Figure 2A, doe] cells do not progress through the cell cycle at 37C.
FACS analysis shows that even after four hours at 37C, only some of the doe] cells have
undergone DNA replication (Figure 2B). Additionally, after only 40 minutes at 37C,
doe] mutant cells exhibit altered spindle morphology that makes analysis of spindle
progression difficult. doe] cells at 37C seem to have a fragmented spindle and this may
explain why these cells cannot progress through the cell cycle. Since doe] cells are
temperature-sensitive even below 37°C, it would be interesting to repeat this experiment
at 300C and see if the spindles remain intact, and if so, where in the cell cycle the doe]
mutants arrest.
doe2 cells show a delay in anaphase entry compared to wild type cells and after
four hours, doe2 cells are unable to exit from mitosis (Figure 3). doe3 cells seem to have
problems in both metaphase and anaphase, as metaphase entry is delayed and cells do not
synchronously enter anaphase (Figure 4). doe4 cells show at least a one hour delay in
replicating their DNA and in entering metaphase (Figure 5). Additionally, doe4 cells do
not synchronously progress through anaphase (Figure 5). Since these doe mutants do
have cell cycle problems in mitosis, they might likely represent components of the MEN
and thus the identification of which genes are mutated in these strains could define
members of the MEN.
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Figure 2: doel does not progress through the cell cycle at 370
Wild type (A2587) and backcrossed once doel (K33) cells were arrested in GI with a-factor
(5mg/mL) in YEPD medium at 250C followed by release into YEPD medium lacking phermone
at 37°C. Samples were taken at the indicated time points after release.
(A) The percentage of cells with metaphase spindles (open symbols) and anaphase spindles
(closed symbols) was determined.
(B) The extent of DNA replication that occurred was measured using FACS analysis.
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Figure 3: doe2 cells show an anaphase delay at 370
Wild type (A2587) and backcrossed once doe2 (K100) cells were arrested in G with a-factor
(5mg/mL) in YEPD medium at 250C followed by release into YEPD medium lacking phermone
at 370C. Samples were taken at the indicated time points after release.
(A) The percentage of cells with metaphase spindles (open symbols) and anaphase spindles
(closed symbols) was determined.
(B) The extent of DNA replication that occurred was measured using FACS analysis.
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Figure 4: doe3 cells show a metaphase and anaphase delay at 370
Wild type (A2587) and backcrossed once doe3 (K173) cells were arrested in GI with a-factor
(5mg/mL) in YEPD medium at 250C followed by release into YEPD medium lacking phermone
at 37oC. Samples were taken at the indicated time points after release.
(A) The percentage of cells with metaphase spindles (open symbols) and anaphase spindles
(closed symbols) was determined.
(B) The extent of DNA replication that occurred was measured using FACS analysis.
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Figure 5: doe4 cells show a metaphase and anaphase delay at 370
Wild type (A2587) and backcrossed once doe4 (K194) cells were arrested in G with ax-factor
(5mg/mL) in YEPD medium at 250C followed by release into YEPD medium lacking phermone
at 370C. Samples were taken at the indicated time points after release.
(A) The percentage of cells with metaphase spindles (open symbols) and anaphase spindles
(closed symbols) was determined.
(B) The extent of DNA replication that occurred was measured using FACS analysis.
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One characteristic of MEN mutants is that they can exit from mitosis if placed
under hypertonic stress by growing the mutant cells in the presence of sorbitol (6). This
rescue is due to signaling through the Shol branch of the high osmolarity glycerol (HOG)
pathway (6). It has been previously shown that the temperature sensitivity of doe3
diploids and doe4 diploids can be suppressed when grown in the presence of sorbitol (2).
In order to reconfirm this in haploids, haploid strains for each of the doe mutants were
tested for growth on sorbitol at 370C. The temperature sensitive growth of both doe3 and
doe4 were again rescued by addition of sorbitol to the media (data not shown). Deletion
of SHO1 from MEN mutants, prevents rescue of 370 C growth in the presence of sorbitol
(6). Therefore, the growth at 37C was tested in doe3 sholA and doe4 sholA strains.
Surprisingly, even without SH01, doe3 and doe4 temperature sensitive growth was still
rescued in the presence of sorbitol (data not shown). Therefore, it is important to identify
the genes mutated in doe3 and doe4 to determine if they are truly mutants in proteins
involved in the MEN, since they do not behave in these assays like previously defined
MEN components.
Identification of which genes are mutated in doe mutant strains
In order to determine if these doe mutants are recessive mutations in the same
gene or in different genes, each doe mutant was crossed to each other at 250C to form
diploids. If these diploids can grow at 37C, this indicates that the two doe mutants
complement each other and are mutations in different genes. If however, these diploids
are unable to grow at 370C, this implies that each doe mutant harbors a mutation in the
same gene. All combinations of doe diploids grew except for the doel/doe3 diploid,
164
implying that doel and doe3 strains have mutations in the same gene, a gene that is not
mutated in doe2 or doe4 (data not shown).
Recently, a technique has been established to identify over ninety percent of all
single nucleotide polymorphisms (SNPs) in the genome of a yeast strain (4). Instead of
sequencing the whole genome, this technique uses microarrays to detect sequence
variations by comparing hybridization intensities of overlapping twenty-five nucleotide
long oligomers spaced five nucleotides apart on the genome, such that each nucleotide in
the genome will be covered by at least five oligomers. Algorithms compare the extent of
hybridization of each probe that covers a nucleotide and predict the likelihood of a SNP
at each nucleotide in the genome. Some caveats of this method are that repetitive regions
of the genome increase the rate of false predictions and that once a prediction is made,
that region must then be sequenced to determine exactly what the changes in sequence
are.
Collaborating with the creator of this technique, we sought to identify the SNPs in
the doe mutant strains relative to a wild type strain. Initially, doe2 and doe3 were
submitted for analysis. Unfortunately, doe2 had so many predicted SNPs that it was not
feasible to check them all by sequencing. doe3 however had 18 predicted SNPs: 7 in
characterized genes, 1 in an uncharacterized gene, 1 in a dubious protein open reading
frame (ORF), 5 hits in intergenic regions, and 4 hits in retrotransposition elements that
are likely false positives. In doe3, characterized genes were sequenced to find possible
nucleotide changes, and most of the predicted SNPs did exist (Table 2).
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Table 2: Analysis of predicted SNPs in doe3
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Gene in Predicted bp Nucleotide Affect on Structural Ability of
which there is (after start) to sequence amino acids location of deletion/mutant
a predicted have SNP results in protein this amino to complement
SNP acid doe3 at 37 0C
1552 518 Not in
Rga2 1549 C to A H to N important Yes
structure
973 325 In RhoGAP
Sac7 971 G to T D to Y domain Yes
was not
Lsb3 460 sequenced - _ Yes
1024 342 Borders
Bud2 1022 C to T Unchanged GTPase Yes
(L) domain
no change in
Scs7 993 bp 465 to _ Yes
stop
2908 970 Borders
Myo2 2903 G to A E to K myosin Yes
domain
654 218 In WD40
Makl 1 650 C to G A to G repeat Untested
2080 694 Structure is
YJR061W 2078 C to T P to S undefined Yes
was not
YBR178W 214 sequenced - - Yes
Having established by sequencing that more than one gene is mutated in doe3, it
was important to determine which of the mutated genes was responsible for the
temperature-sensitive growth phenotype of doe3 that has been characterized. Since seven
of the nine genes in Table 2 are non-essential, doe3 was crossed to seven strains, each
with one of the non-essential genes deleted and the resulting doe/deletion diploids were
tested for ability to grow at 370C. All seven of the diploids, were able to complement the
temperature sensitive lethality at 37C, indicating that none of these seven genes are
responsible for the temperature sensitive growth of doe3 (Table 2). The two remaining
genes on this list of possible doe3 mutated genes, MAK]I and MY02, are essential.
However, a temperature sensitive allele of MY02 exists and was tested for ability to
complement doe3 at 370 C. Unlike each haploid strain, a myo2-66/doe3 diploid was able
to grow at 37C, indicating that the sequence changes in Myo2 in doe3 are not
responsible for its temperature sensitive growth (Table 2). This leaves only MAKll from
the list of predicted genes with mutations in doe3 that could be responsible for the
temperature sensitive phenotype (Table 2). Makl 1 is involved in ribosome assembly in
yeast, but has not yet been implicated in mitotic exit (5). To date, it remains to be
confirmed that the mutation in MAK 1 causes the temperature sensitivity of the doe3
cells.
Complementation of doe mutants by over-expression of other MEN components
If the doe mutants are involved in mitotic exit, then one prediction is that over-
expression of other MEN components would also rescue their temperature sensitive
growth. To test this, each doe mutant was crossed to strains with the other two MEN
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kinases over-expressed. For example, doel was originally isolated in the screen with
GAL-DBF2, so now the ability of doel GAL- CDC5 and doel GAL-CDC15 strains to
grow at 370 C on media with or without galactose was tested. Table 3 indicates the results
for these growth experiments on doel-4. Although there is some variability in the extent
of rescue, over-expression of kinases involved in the MEN improves the growth of the
doe mutants at 37C.
In the process of making the doe strains over-expressing different MEN kinases,
backcrossed doe mutants were also generated. These backcrossed strains were also tested
for growth at 370 C on media with or without galactose, as a negative control for growth.
Surprisingly, backcrossed doel, doe3, and doe4 strains without any over-expression
kinase constructs were able to grow on media with galactose at 370C (Figure 6 and data
not shown). This implies that rescue of temperature sensitivity seen on galactose for
these three strains is not actually due to the over-expressed MEN kinase, but instead must
be due to enhanced fitness when galactose is metabolized instead of glucose. These three
doe strains must have somehow escaped the initial categorization as false positive. doe2
however, still retains the true phenotype, as its growth at 370C on galactose is dependent
on the presence of an over-expressed MEN kinase (Figure 6).
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GAL-DBF2 doe2
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Figure 6: Only doe2 retains doe phenotype
(A) GAL-DBF2 doel (K34), backcrossed once doel (K33), backcrossed twice
doel (B9), GAL-CDC5 doe] (B19), and GAL-CDC5 doel (B20) cells were grown
at indicated temperatures for three days on solid media with galactose.
(B) GAL-CDC5 doe2 (K99), backcrossed once doe2 (K102), backcrossed twice
doe2 (B12), backcrossed three times doe2 (B14), GAL-CDC15 doe2 (B21), and
GAL-DBF2 doe2 (B21) cells were grown at indicated temperatures for three days
on solid media with galactose.
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Table 3: Comparative doe mutant growth with all GAL MEN constructs
+ indicates growth
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1. Mutant tested 2. Original screen 3. Other GAL 4. Other GAL
isolate construct #1 construct #2
Doel Dbf2 ++ Cdc5 + Cdcl5 +++
Doe2 Cdc5 ++ Dbf2 + Cdcl5 ++
Doe3 Cdc 15 ++ Dbf2 +++ Cdc5 ++
Doe4 Cdc 15 ++ Cdc5 ++ Dbf2 ++
Identification of doe2 as a new mutant of Cdcl4
To identify the gene mutated in the doe2 strain, diploids were made with mutants
involved in mitotic exit: cdc15-2, teml-3, cdc14-3, dbJ2-2, mobl-77, cdc5-1. All
resulting diploids were able to complement doe2 temperature sensitive growth except the
cdcl4 mutant (data not shown). The ORF of Cdcl4 was sequenced in the doe2 strain and
a mutation was found: nucleotide 545 is normally a cytosine (C) and in doe2 is a thymine
(T), which changes amino acid 182 in Cdcl4 from a threonine (T) in wild type to an
isoleucine (I) in doe2. Interestingly, there was no SNP predicted in cdcl4 from our
collaborator's hybridization array. This region of the Cdcl4 protein is not in any
currently known core structural element of the protein.
Crossing doe2 to a strain in which Cdcl4 is tagged with an auxotrophic marker,
showed that these two genes are linked because all the resulting spores always were
either temperature sensitive or had the marker (data not shown). A control that remains
to be tested is transforming doe2 cells with a plasmid containing CDC14 and showing
that the presence of this plasmid rescues the temperature-sensitivity of doe2.
Additionally, making the single nucleotide change C545T in CDC14 in an otherwise
wild-type strain background and then checking for the establishment of a doe phenotype
would be a good confirmation of our current hypothesis that the temperature sensitivity
of doe2 is due to the mutation in cdcl4. Over-expression of MEN kinases were tested for
their ability to rescue the growth at 37C of two known Cdcl4 temperature sensitive
mutants, cdcl4-3 and cdcl4-1. However, neither of these two temperature sensitive
strains were able to grow at 370C on galactose with over-expressed MEN kinases (data
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Figure 7: cdcl4-doe2 localization at 370
Twice backcrossed doe2 (B37) cells were arrested in GI with a-factor (5pg/mL) in
YEPD medium at 250C followed by release into YEPD medium lacking phermone at
37 0C. Samples were taken at the indicated time points after release and stained by
indirect immunofluorescence for tubulin (green), Cdcl4 (Red) and DNA (blue). The
arrow indicates a metaphase cell which shows premature release of Cdc 14.
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not shown). This indicates, there is something specific about the cdcl4-doe2 allele that
allows it to be rescued by a hyperactive MEN.
cdcl4-T182E and cdc14-T182A mutations were previously made in the lab and
tested for their ability to localize properly and grow at 370C in a cdcl4-3 background
(Rosella Visintin, unpublished observations). cdcl4-T182E complemented the growth at
37°C of a cdcl4-3 strain. cdcl4-T182A could also complement growth at 370C of a
cdcl4-3 strain, but was very slow growing. Additionally, the cdc14-T182A in a cdcl4-3
strain could localize properly at 250C but not at 370 C. Whereas, cdc14-T182A in a
CDC14 strain could localize properly at both 250 C and 37°C. One caveat of these
experiments is that the wild-type Cdcl4 could be localizing the mutant Cdc 14 properly
since Cdcl4 forms dimers. Since the cdcl4-doe2 strain has no other copies of Cdcl4,
examining the localization of this allele of cdcl4 in doe2 would indicate directly if this
mutation affects localization. In fact, cdcl4-doe2 does have an altered localization
compared to wild type at 37C (Figure 7). cdcl4-doe2 seems to be prematurely released
from the nucleolus as seen in cells in metaphase.
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Discussion and Future Experiments
This screen was conducted to identify positive regulators of mitotic exit. Mutants
were analyzed for their growth dependence on the overexpression of one of the three
MEN kinases CDC5, CDC15, and DBF2. This approach involves the assumption that the
partial loss of function mutants in this essential pathway generated by mutagen treatment
can be rescued by overexpression of these MEN kinases. Almost thirty alleles of known
MEN components TEM1, CDC5, and DBF2 were identified, validating the assumptions
made in the setup of this screen. Additionally, 19 unknown mutants were discovered,
four of which displayed a strong phenotype and were termed dependent on
overexpression mutants (doel-4). These mutants were shown to be temperature-sensitive
recessive mutants all with cell cycle defects. The growth of these mutants was enhanced
by overexpression of any of the three MEN kinases. doe] and doe3 strains are likely
mutations in the same gene, and doe3 may be a mutation in MAK11. doe2 was the only
one of the four to retain its galactose dependency at the restrictive temperature after
backcrossing. doe2 identified as a novel allele of Cdcl4 with a T182I mutation whose
localization was altered at the restrictive temperature. Unfortunately, no new
components involved in mitotic exit have been identified from this screen to date. This
may be due to the fact that there are no additional components of the MEN that exist or
that the screen was not fully saturated and therefore some potential mutants were missed.
As the MEN continues to be studied, it will be interesting to see if any new components
will be identified or if all the key components have already been previously established.
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Future experiments can be conducted to better characterize the cdcl4-doe2 allele.
To date, it is unclear whether cdcl4-doe2 simply becomes released prematurely once
cells progress into metaphase or if while growing at 37C the mutant protein becomes
unfolded and therefore mislocalized. One way to examine this would be to arrest cdcl4-
doe2 cells and wild type cells in G 1 by addition of the mating phermone alpha-factor.
Once arrested, the cells can split into two populations, both of which will remain arrested,
but one will be kept at 250C and the other will be put at the restrictive temperature of
370C. If the Cdcl4-doe2 protein just becomes unfolded after growth at 370C, then the
expectation is to see mislocalized Cdcl4 only in the cdc14-T182A population at 370C. If
this is seen, then further work could be done to test how this part of the protein is
important for proper folding. However, if Cdc 14-doe2 protein simply gets released
prematurely once cells enter metaphase, then the expectation would be that Cdc 14-doe2
protein remains sequestered even at 37C in this experiment, because these cells will
remain arrested in G1.
Other interesting experiments that could be done include over-expressing MEN
kinases and examining how that affects the localization of Cdc 14-doe2 at 370C. If over-
expressing MEN kinases rescues the localization of Cdc 14-doe2 at 370 C, this may
explain why the temperature-sensitive lethality of doe2 cells can be rescued by over-
expressing MEN kinases. Lastly, it may be interesting to test the ability of the Cdc 14-
doe2 protein in phosphatase assays to see if normal Cdcl4 phosphatase activity is
affected by this single nucleotide sequence change. Although characterizing the doe
mutants did not directly implicate new proteins as being involved in mitotic exit, a novel
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cdcl4 mutant has been identified that once further explored, may shed more light on how
Cdcl4 normally functions to promote exit from mitosis.
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Materials and Methods
Yeast strains
All yeast strains used are derived from W303 (K699).
Mutagenesis procedure of screen
GAL-DBF2 (A2546), GAL-CDC5 (A4083), GAL-CDC15 (A5211) cells in stationary
phase were treated with ethyl methanesulfonate (EMS) for 90 minutes, such that survival
rate is 50%. 1000 cells/plate were spread on galactose. Cells were replica plated onto
glucose + Phloxin B (10mg/L) and raffinose + galactose + Phloxin B and incubated at 30
degrees Celsius. The selected 77 colonies did not grow on glucose (were red), but were
able to grow on raffinose + galactose (cells were white/pink) (2).
Cell synchronization
Cells were arrested in G in YEPD medium containing 5[g/ml alpha-factor at room
temperature. Once arrested, cells were released by washing out alpha-factor and then
were resuspended in YEPD at 370 C.
Immunofluorescence
Tubulin was visualized with anti-tubulin antibodies, Cdcl4 was visualized by goat anti-
Cdcl4 antibody, and DNA was stained with DAPI according to indirect
immunofluorescence protocols established previously (8).
SNP predictions by microarray
Tiling array on doe2 (K100) and doe3 (K173) was conducted by Dr. Maitreya Dunham as
previous described (4).
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